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Foreword 
 
The evaluation of research and doctoral training is being carried out in the years 2010–2012 and will end in 
2012. The steering group appointed by the Rector in January 2010 set the conditions for participating in 
the evaluation and prepared the Terms of Reference to present the evaluation procedure and criteria. The 
publications and other scientific activities included in the evaluation covered the years 2005–2010. 
The participating unit in the evaluation was defined as a Researcher Community (RC). To obtain a 
critical mass with university-level impact, the number of members was set to range from 20 to 120. The 
RCs were required to contain researchers in all stages of their research career, from doctoral students to 
principal investigators (PIs). All in all, 136 Researcher Communities participated in this voluntary 
evaluation, 5857 persons in total, of whom 1131 were principal investigators. PIs were allowed to 
participate in two communities in certain cases, and 72 of them used this opportunity and participated in 
two RCs. 
This evaluation enabled researchers to define RCs from the “bottom up” and across disciplines. The aim 
of the evaluation was not to assess individual performance but a community with shared aims and 
researcher-training activities. The RCs were able to choose among five different categories that 
characterised the status and main aims of their research. The steering group considered the process of 
applying to participate in the evaluation to be important, which lead to the establishment of these 
categories. In addition, providing a service for the RCs to enable them to benchmark their research at the 
global level was a main goal of the evaluation. 
The data for the evaluation consisted of the RCs’ answers to evaluation questions on supplied e-forms 
and a compilation extracted from the TUHAT – Research Information System (RIS) on 12 April 2011. The 
compilation covered scientific and other publications as well as certain areas of scientific activities. During 
the process, the RCs were asked to check the list of publications and other scientific activities and make 
corrections if needed. These TUHAT compilations are public and available on the evaluation project sites 
of each RC in the TUHAT-RIS. 
In addition to the e-form and TUHAT compilation, University of Leiden (CWTS) carried out bibliometric 
analyses from the articles included in the Web of Science (WoS). This was done on University and RC 
levels. In cases where the publication forums of the RC were clearly not represented by the WoS data, the 
Library of the University of Helsinki conducted a separate analysis of the publications. This was done for 
66 RCs representing the humanities and social sciences. 
The evaluation office also carried out an enquiry targeted to the supervisors and PhD candidates about 
the organisation of doctoral studies at the University of Helsinki. This and other documents describing the 
University and the Finnish higher education system were provided to the panellists. 
The panel feedback for each RC is unique and presented as an entity. The first collective evaluation 
reports available for the whole panel were prepared in July–August 2011. The reports were accessible to all 
panel members via the electronic evaluation platform in August. Scoring from 1 to 5 was used to 
complement written feedback in association with evaluation questions 1–4 (scientific focus and quality, 
doctoral training, societal impact, cooperation) and in addition to the category evaluating the fitness for 
participation in the evaluation. Panellists used the international level as a point of comparison in the 
evaluation. Scoring was not expected to go along with a preset deviation. 
Each of the draft reports were discussed and dealt with by the panel in meetings in Helsinki (from 11 
September to 13 September or from 18 September to 20 September 2011). In these meetings the panels 
also examined the deviations among the scores and finalised the draft reports together. 
The current RC-specific report deals shortly with the background of the evaluation and the terms of 
participation. The main evaluation feedback is provided in the evaluation report, organised according to 
the evaluation questions. The original material provided by the RCs for the panellists has been attached to 
these documents. 
 
 
 
 
 
 
 
 
 
On behalf of the evaluation steering group and office, I sincerely wish to thank you warmly for your 
participation in this evaluation. The effort you made in submitting the data to TUHAT-RIS is gratefully 
acknowledged by the University. We wish that you find this panel feedback useful in many ways. The 
bibliometric profiles may open a new view on your publication forums and provide a perspective for 
discussion on your choice of forums. We especially hope that this evaluation report will help you in setting 
the future goals of your research. 
 
Johanna Björkroth 
Vice-Rector 
Chair of the Steering Group of the Evaluation 
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Panel members 
CHAIR 
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Karolinska Institute, Sweden 
 
VICE-CHAIR 
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The panel, independently, evaluated all the submitted material and was responsible for the 
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discussion and report writing. 
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Finland 
 
Professor Anders Linde 
Oral biochemi 
Faculty of Odontology 
Göteborg University 
Sweden 
 
 
2 
 
Experts from the Other Panels 
Professor Jan-Otto Carlsson, from the Panel of Natural Sciences 
Professor Danny Huylebroek, from the Panel of Biological, Agricultural and Veterinary 
Sciences 
Professor Holger Stark, from the Panel of Natural Sciences 
 
 
 
 
 
EVALUATION OFFICE 
Dr Seppo Saari, Doc., Senior Adviser in Evaluation, was responsible for the entire 
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Mrs Aija Kaitera, Project Manager of TUHAT-RIS served the project ex officio 
providing the evaluation project with the updated information from TUHAT-RIS. 
The TUHAT office assisted in mapping the publications with CWTS/University of 
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MA Liisa Ekebom, Assisting Officer, served in TUHAT-RIS updating the 
publications for the evaluation. She also assisted the UH/Library analyses. 
BA Liisa Jäppinen, Assisting Officer, served in TUHAT-RIS updating the 
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HELSINKI UNIVERSITY LIBRARY 
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sciences and in other fields of sciences where CWTS analyses were not 
applicable. 
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Acronyms and abbreviations applied in the report 
 
External competitive funding 
AF – Academy of Finland 
TEKES - Finnish Funding Agency for Technology and Innovation  
EU - European Union 
ERC - European Research Council 
International and national foundations 
FP7/6 etc. /Framework Programmes/Funding of European Commission 
 
Evaluation marks 
Outstanding (5) 
Excellent  (4) 
Very Good  (3) 
Good  (2) 
Sufficient  (1) 
 
Abbreviations of Bibliometric Indicators 
P - Number of publications 
TCS – Total number of citations 
MCS - Number of citations per publication, excluding self-citations 
PNC - Percentage of uncited publications 
MNCS - Field-normalized number of citations per publication 
MNJS - Field-normalized average journal impact 
THCP10 - Field-normalized proportion highly cited publications (top 10%) 
INT_COV - Internal coverage, the average amount of references covered by the WoS 
WoS – Thomson Reuters Web of Science Databases 
 
Participation category 
Category 1. The research of the participating community represents the international cutting edge in its 
field. 
Category 2. The research of the participating community is of high quality, but the community in its 
present composition has yet to achieve strong international recognition or a clear break-through. 
Category 3. The research of the participating community is distinct from mainstream research, and the 
special features of the research tradition in the field must be considered in the evaluation. 
Category 4. The research of the participating community represents an innovative opening. 
Category 5. The research of the participating community has a highly significant societal impact. 
 
Research focus areas of the University of Helsinki 
Focus area 1: The basic structure, materials and natural resources of the physical world 
Focus area 2: The basic structure of life 
Focus area 3: The changing environment – clean water 
Focus area 4: The thinking and learning human being 
Focus area 5: Welfare and safety 
Focus area 6: Clinical research 
Focus area 7: Precise reasoning 
Focus area 8: Language and culture 
Focus area 9: Social justice 
Focus area 10: Globalisation and social change 
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1 Introduction to the Evaluation 
1.1 RC-specific evaluation reports 
The participants in the evaluation of research and doctoral training were Researcher Communities 
(hereafter referred to as the RC). The RC refers to the group of researchers who registered together in the 
evaluation of their research and doctoral training. Preconditions in forming RCs were stated in the 
Guidelines for the Participating Researcher Communities. The RCs defined themselves whether their 
compositions should be considered well-established or new. 
It is essential to emphasise that the evaluation combines both meta-evaluation1 and traditional 
research assessment exercise and its focus is both on the research outcomes and procedures associated 
with research and doctoral training. The approach to the evaluation is enhancement-led where self-
evaluation constituted the main information. The answers to the evaluation questions formed together 
with the information of publications and other scientific activities an entity that was to be reviewed as a 
whole. 
The present evaluation recognizes and justifies the diversity of research practices and publication 
traditions. Traditional Research Assessment Exercises do not necessarily value high quality research with 
low volumes or research distinct from mainstream research. It is challenging to expose the diversity of 
research to fair comparison. To understand the essence of different research practices and to do justice to 
their diversity was one of the main challenges of the present evaluation method. Understanding the 
divergent starting points of the RCs demanded sensitivity from the evaluators. 
1.2 Aims and objectives in the evaluation 
The aims of the evaluation are as follows: 
 to improve the level of research and doctoral training at the University of Helsinki and to raise 
their international profile in accordance with the University’s strategic policies. The improvement 
of doctoral training should be compared to the University’s policy.2 
 to enhance the research conducted at the University by taking into account the diversity, 
originality, multidisciplinary nature, success and field-specificity, 
 to recognize the conditions and prerequisites under which excellent, original and high-impact 
research is carried out, 
 to offer the academic community the opportunity to receive topical and versatile international 
peer feedback, 
 to better recognize the University’s research potential. 
 to exploit the University’s TUHAT research information system to enable transparency of 
publishing activities and in the production of reliable, comparable data. 
1.3 Evaluation method 
The evaluation can be considered as an enhancement-led evaluation. Instead of ranking, the main aim is to 
provide useful information for the enhancement of research and doctoral training of the participating RCs. 
The comparison should take into account each field of science and acknowledge their special character. 
                                                                
1 The panellists did not read research reports or abstracts but instead, they evaluated answers to the evaluation 
questions, tables and compilations of publications, other scientific activities, bibliometrics or comparable analyses. 
2
 Policies on doctoral degrees and other postgraduate degrees at the University of Helsinki.  
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The comparison produced information about the present status and factors that have lead to success. Also 
challenges in the operations and outcomes were recognized. 
The evaluation approach has been designed to recognize better the significance and specific nature of 
researcher communities and research areas in the multidisciplinary top-level university. Furthermore, one 
of the aims of the evaluation is to bring to light those evaluation aspects that differ from the prevalent 
ones. Thus the views of various fields of research can be described and research arising from various 
starting points understood better. The doctoral training is integrated into the evaluation as a natural 
component related to research. Operational processes of doctoral training are being examined in the 
evaluation. 
 
Five stages of the evaluation method were: 
1. Registration – Stage 1 
2. Self-evaluation – Stage 2 
3. TUHAT3 compilations on publications and other scientific activities4 
4. External evaluation 
5. Public reporting 
1.4 Implementation of the external evaluation 
Five Evaluation Panels 
Five evaluation panels consisted of independent, renowned and highly respected experts. The main 
domains of the panels are: 
1. biological, agricultural and veterinary sciences 
2. medicine, biomedicine and health sciences 
3. natural sciences 
4. humanities 
5. social sciences 
The University invited 10 renowned scientists to act as chairs or vice-chairs of the five panels based on 
the suggestions of faculties and independent institutes. Besides leading the work of the panel, an 
additional role of the chairs was to discuss with other panel chairs in order to adopt a broadly similar 
approach. The panel chairs and vice-chairs had a pre-meeting on 27 May 2011 in Amsterdam. 
The panel compositions were nominated by the Rector of the University 27 April 2011. The participating 
RCs suggested the panel members. The total number of panel members was 50. The reason for a smaller 
number of panellists as compared to the previous evaluations was the character of the evaluation as a 
meta-evaluation. The panellists did not read research reports or abstracts but instead, they evaluated 
answers to the evaluation questions, tables and compilations of publications, other scientific activities, 
bibliometrics and comparable analyses. 
 
The panel meetings were held in Helsinki: 
 On 11–13 September 2011: (1) biological, agricultural and veterinary sciences, (2) medicine, 
biomedicine and health sciences and (3) natural sciences.  
 On 18–20 September 2011: (4) humanities and (5) social sciences. 
  
                                                                
3 TUHAT (acronym) of Research Information System (RIS) of the University of Helsinki 
4 Supervision of thesis, prizes and awards, editorial work and peer reviews, participation in committees, boards and 
networks and public appearances. 
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1.5 Evaluation material 
The main material in the evaluation was the RCs’ self-evaluations that were qualitative in character and 
allowed the RCs to choose what was important to mention or emphasise and what was left unmentioned. 
The present evaluation is exceptional at least in the Finnish context because it is based on both the 
evaluation documentation (self-evaluation questions, publications and other scientific activities) and the 
bibliometric reports. All documents were delivered to the panellists for examination. 
Traditional bibliometrics can be reasonably done mainly in medicine, biosciences and natural sciences 
when using the Web of Science database, for example. Bibliometrics, provided by CWTS/The Centre for 
Science and Technology Studies, University of Leiden, cover only the publications that include WoS 
identification in the TUHAT-RIS. 
Traditional bibliometrics are seldom relevant in humanities and social sciences because the 
international comparable databases do not store every type of high quality research publications, such as 
books and monographs and scientific journals in other languages than English. The Helsinki University 
Library has done analysis to the RCs, if their publications were not well represented in the Web of Science 
databases (RCs should have at least 50 publications and internal coverage of publications more than 40%) 
– it meant 58 RCs. The bibliometric material for the evaluation panels was available in June 2011. The RC-
specific bibliometric reports are attached at the end of each report. 
The panels were provided with the evaluation material and all other necessary background information, 
such as the basic information about the University of Helsinki and the Finnish higher education system. 
 
Evaluation material 
1. Registration documents of the RCs for the background information 
2. Self evaluation material – answers to the evaluation questions 
3. Publications and other scientific activities based on the TUHAT RIS: 
3.1. statistics of publications 
3.2. list of publications 
3.3. statistics of other scientific activities 
3.4. list of other scientific activities 
4. Bibliometrics and comparable analyses: 
4.1. Analyses of publications based on the verification of TUHAT-RIS publications with the Web 
of Science publications (CWTS/University of Leiden) 
4.2. Publication statistics analysed by the Helsinki University Library - mainly for humanities and 
social sciences 
5. University level survey on doctoral training (August 2011) 
6. University level analysis on publications 2005–2010 (August 2011) provided by CWTS/University 
of Leiden 
 
Background material 
 
University of Helsinki 
- Basic information about the University of the Helsinki 
- The structure of doctoral training at the University of Helsinki 
- Previous evaluations of research at the University of Helsinki – links to the reports: 1998 and 2005 
 
The Finnish Universities/Research Institutes 
- Finnish University system 
- Evaluation of the Finnish National Innovation System 
- The State and Quality of Scientific Research in Finland. Publication of the Academy of Finland 
9/09. 
 
The evaluation panels were provided also with other relevant material on request before the meetings in 
Helsinki. 
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1.6 Evaluation questions and material 
The participating RCs answered the following evaluation questions which are presented according to the 
evaluation form. In addition, TUHAT RIS was used to provide the additional material as explained. For 
giving the feedback to the RCs, the panellists received the evaluation feedback form constructed in line 
with the evaluation questions: 
 
1. Focus and quality of the RC’s research 
 Description of 
- the RC’s research focus. 
- the quality of the RC’s research (incl. key research questions and results) 
- the scientific significance of the RC’s research in the research field(s) 
 Identification of the ways to strengthen the focus and improve the quality of the RC’s research 
The additional material: TUHAT compilation of the RC’s publications, analysis of the RC’s publications data 
(provided by University of Leiden and the Helsinki University Library) 
A written feedback from the aspects of: scientific quality, scientific significance, societal impact, 
innovativeness 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
2. Practises and quality of doctoral training 
 Organising of the doctoral training in the RC. Description of the RC’s principles for: 
- recruitment and selection of doctoral candidates 
- supervision of doctoral candidates 
- collaboration with faculties, departments/institutes, and potential graduate schools/doctoral 
programmes 
- good practises and quality assurance in doctoral training 
- assuring of good career perspectives for the doctoral candidates/fresh doctorates 
 Identification of the RC’s strengths and challenges related to the practises and quality of doctoral 
training, and the actions planned for their development. 
The additional material: TUHAT compilation of the RC’s other scientific activities/supervision of doctoral 
dissertations 
A written feedback from the aspects of: processes and good practices related to leadership and 
management 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
3. The societal impact of research and doctoral training 
 Description on how the RC interacts with and contributes to the society (collaboration with 
public, private and/or 3rd sector). 
 Identification of the ways to strengthen the societal impact of the RC’s research and doctoral 
training. 
The additional material: TUHAT compilation of the RC’s other scientific activities. 
A written feedback from the aspects of: societal impact, national and international collaboration, 
innovativeness 
 
  Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
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4. International and national (incl. intersectoral) research collaboration and researcher mobility 
 Description of  
- the RC’s research collaborations and joint doctoral training activities 
- how the RC has promoted researcher mobility 
 Identification of the RC’s strengths and challenges related to research collaboration and 
researcher mobility, and the actions planned for their development. 
A written feedback from the aspects of: scientific quality, national and international collaboration 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
5. Operational conditions  
 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties). 
 Identification of the RC’s strengths and challenges related to operational conditions, and the 
actions planned for their development. 
A written feedback from the aspects of: processes and good practices related to leadership and 
management 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
6. Leadership and management in the researcher community 
 Description of 
- the execution and processes of leadership in the RC 
- how the management-related responsibilities and roles are distributed in the RC 
- how the leadership- and management-related processes support 
- high quality research 
- collaboration between principal investigators and other researchers in the RC 
the RC’s research focus 
- strengthening of the RC’s know-how 
 Identification of the RC’s strengths and challenges related to leadership and management, and 
the actions planned for developing the processes 
 
7. External competitive funding of the RC 
 The RCs were asked to provide information of such external competitive funding, where: 
- the funding decisions have been made during 1.1.2005-31.12.2010, and 
- the administrator of the funding is/has been the University of Helsinki 
 On the e-form the RCs were asked to provide: 
1) The relevant funding source(s) from a given list (Academy of Finland/Research Council, TEKES/The 
Finnish Funding Agency for Technology and Innovation , EU, ERC, foundations, other national funding 
organisations, other international funding organisations), and 
2)The total sum of funding which the organisation in question had decided to allocate to the RCs 
members during 1.1.2005–31.12.2010. 
 
Competitive funding reported in the text is also to be considered when evaluating this point. 
A written feedback from the aspects of: scientific quality, scientific significance, societal impact, 
innovativeness, future significance 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
8. The RC’s strategic action plan for 2011–2013 
 RC’s description of their future perspectives in relation to research and doctoral training. 
A written feedback from the aspects of: scientific quality, scientific significance, societal Impact, processes 
and good practices related to leadership and management, national and international collaboration, 
innovativeness, future significance 
 Strengths 
 Areas of development 
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 Other remarks 
 Recommendations 
 
9. Evaluation of the category of the RC in the context of entity of the evaluation material (1-8) 
 
The RC’s fitness to the chosen participation category 
A written feedback evaluating the RC’s fitness to the chosen participation category  
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
10. Short description of how the RC members contributed the compilation of the stage 2 material 
Comments on the compilation of evaluation material 
 
11. How the UH’s focus areas are presented in the RC’s research? 
Comments if applicable 
 
12. RC-specific main recommendations based on the previous questions 1–11 
 
13. RC-specific conclusions 
1.7 Evaluation criteria 
The panellists were expected to give evaluative and analytical feedback to each evaluation question 
according to their aspects in order to describe and justify the quality of the submitted material. In 
addition, the evaluation feedback was asked to be pointed out the level of the performance according to 
the following classifications: 
 outstanding  (5) 
 excellent  (4) 
 very good  (3) 
 good   (2) 
 sufficient  (1) 
 
Evaluation according to the criteria was to be made with thorough consideration of the entire 
evaluation material of the RC in question. Finally, in questions 1-4 and 9, the panellists were expected to 
classify their written feedback into one of the provided levels (the levels included respective descriptions, 
‘criteria’). Some panels used decimals in marks. The descriptive level was interpreted according to the 
integers and not rounding up the decimals by the editors. 
 
Description of criteria levels 
Question 1 – FOCUS AND QUALITY OF THE RC’S RESEARCH 
 
Classification: Criteria (level of procedures and results) 
Outstanding quality of procedures and results (5) 
Outstandingly strong research, also from international perspective. Attracts great international 
interest with a wide impact, including publications in leading journals and/or monographs published 
by leading international publishing houses. The research has world leading qualities. The research 
focus, key research questions scientific significance, societal impact and innovativeness are of 
outstanding quality. 
In cases where the research is of a national character and, in the judgement of the evaluators, should 
remain so, the concepts of ”international attention” or ”international impact” etc. in the grading 
criteria above may be replaced by ”international comparability”. 
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Operations and procedures are of outstanding quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are in 
alignment with the documentation. The ambition to develop the community together is of 
outstanding quality. 
Excellent quality of procedures and results (4) 
Research of excellent quality. Typically published with great impact, also internationally. Without 
doubt, the research has a leading position in its field in Finland. 
Operations and procedures are of excellent quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are to 
large extent in alignment with the documentation. The ambition to develop the community together 
is of excellent quality. 
Very good quality of procedures and results (3) 
The research is of such very good quality that it attracts wide national and international attention. 
Operations and procedures are of very good quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are to 
large extent in alignment with the documentation. The ambition to develop the community together 
is of very good quality. 
Good quality of procedures and results (2) 
Good research attracting mainly national attention but possessing international potential, 
extraordinarily high relevance may motivate good research. 
Operations and procedures are of good quality, shared occasionally in the community. The 
improvement of research and other efforts are occasionally documented and operations and 
practices are to large extent in alignment with the documentation. The ambition to develop the 
community together is of good quality. 
Sufficient quality of procedures and results (1) 
In some cases the research is insufficient and reports do not gain wide circulation or do not have 
national or international attention. Research activities should be revised. 
Operations and procedures are of sufficient quality, shared occasionally in the community. The 
improvement of research and other efforts are occasionally documented and operations and 
practices are to some extent in alignment with the documentation. The ambition to develop the 
community together is of sufficient quality. 
 
Question 2 – DOCTORAL TRAINING 
Question 3 – SOCIETAL IMPACT 
Question 4 – COLLABORATION 
 
Classification: Criteria (level of procedures and results) 
Outstanding quality of procedures and results (5) 
Procedures are of outstanding quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are in alignment with the 
documentation. The ambition to develop the community together is of outstanding quality. The 
procedures and results are regularly evaluated and the feedback has an effect on the planning. 
Excellent quality of procedures and results (4) 
Procedures are of excellent quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of excellent quality. The 
procedures and outcomes are evaluated and the feedback has an effect on the planning. 
Very good quality of procedures and results (3) 
Procedures are of very good quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
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management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of very good quality. 
Good quality of procedures and results (2) 
Procedures are of good quality, shared occasionally in the community. The practices and quality of 
doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of good quality. 
Sufficient quality of procedures and results (1) 
Procedures are of sufficient quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are occasionally documented and operations and practices are to some extent in 
alignment with the documentation. The ambition to develop the community together is of sufficient 
quality. 
 
Question 9 – CATEGORY 
Participation category – fitness for the category chosen 
The choice and justification for the chosen category below should be reflected in the RC’s responses to the 
evaluation questions 1–8. 
1. The research of the participating community represents the international cutting edge in its field. 
2. The research of the participating community is of high quality, but the community in its present 
composition has yet to achieve strong international recognition or a clear break-through. 
3. The research of the participating community is distinct from mainstream research, and the special 
features of the research tradition in the field must be considered in the evaluation. The research is 
of high quality and has great significance and impact in its field. However, the generally used 
research evaluation methods do not necessarily shed sufficient light on the merits of the 
research.  
4. The research of the participating community represents an innovative opening. A new opening can 
be an innovative combination of research fields, or it can be proven to have a special social, 
national or international demand or other significance. Even if the researcher community in its 
present composition has yet to obtain proof of international success, its members can produce 
convincing evidence of the high level of their previous research. 
5. The research of the participating community has a highly significant societal impact. The 
participating researcher community is able to justify the high social significance of its research. 
The research may relate to national legislation, media visibility or participation in social debate, 
or other activities promoting social development and human welfare. In addition to having 
societal impact, the research must be of a high standard. 
 
An example of outstanding fitness for category choice (5) 5 
The RC’s representation and argumentation for the chosen category were convincing. The RC recognized 
its real capacity and apparent outcomes in a wider context to the research communities. The specific 
character of the RC was well-recognized and well stated in the responses. The RC fitted optimally for the 
category. 
 
 Outstanding  (5) 
 Excellent  (4) 
 Very good  (3) 
 Good   (2) 
 Sufficient  (1) 
The above-mentioned definition of outstanding was only an example in order to assist the panellists in 
the positioning of the classification. There was no exact definition for the category fitness. 
                                                                
5 The panels discussed the category fitness and made the final conclusions of the interpretation of it. 
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1.8 Timetable of the evaluation 
The main timetable of the evaluation: 
1. Registration   November 2010 
2. Submission of self-evaluation materials  January–February 2011 
3. External peer review    May–September 2011 
4. Published reports    March–April 2012 
- University level public report 
- RC specific reports 
 
The entire evaluation was implemented during the university’s strategy period 2010–2012. The preliminary 
results were available for the planning of the following strategy period in late autumn 2011. The evaluation 
reports will be published in March/April 2012. More detailed time schedule is published in the University 
report. 
1.9 Evaluation feedback – consensus of the entire panel 
The panellists evaluated all the RC-specific material before the meetings in Helsinki and mailed the 
draft reports to the evaluation office. The latest interim versions were on-line available to all the panellists 
on the Wiki-sites. In September 2011, in Helsinki the panels discussed the material, revised the first draft 
reports and decided the final numeric evaluation. After the meetings in Helsinki, the panels continued 
working and finalised the reports before the end of November 2011. The final RC-specific reports are the 
consensus of the entire panel. 
The evaluation reports were written by the panels independently. During the editing process, the 
evaluation office requested some clarifications from the panels when necessary. The tone and style in the 
reports were not harmonized in the editing process. All the reports follow the original texts written by the 
panels as far as it was possible. 
The original evaluation material of the RCs, provided for the panellists is attached at the end of the 
report. It is essential to notice that the exported lists of publications and other scientific activities depend 
how the data was stored in the TUHAT-RIS by the RCs. 
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2 Evaluation feedback 
2.1 Focus and quality of the RC’s research 
 Description of 
 the RC’s research focus 
 the quality of the RC’s research (incl. key research questions and results) 
 the scientific significance of the RC’s research in the research field(s) 
 Identification of the ways to strengthen the focus and improve the quality of the RC’s research 
ASPECTS: Scientific quality, scientific significance, societal impact, innovativeness 
 
DePoNa is composed of a cohort of 57 researchers led by a group of PIs, and is based within three 
academic units of the University of Helsinki (UH) – Centre for Drug Research, Division of Pharmacy and 
Pharmacokinetics and the Laboratory of Polymer Chemistry, with the Laboratory of Polymer Chemistry 
already recognized as a Centre of Excellence in Finland. Four of the PIs joined the RC during the period of 
assessment. The multidisciplinary and focused research lies in drug delivery and polymer based 
nanotechnology, successfully bringing together the range of expertise and resource required for studies in 
these fields. The three groups in the RC are clearly linked via collaborative research outputs and in 
teaching. The research topics are important, in terms of fundamental scientific knowledge and applications 
in the design of medicines for drug delivery to challenging clinical targets, including brain, ophthalmics 
and cancer tumours. With these topics representing areas of major unmet clinical need, the societal impact 
is clearly demonstrated. 
Whilst being composed of a relatively new integration of four PIs and groups into the RC, DePoNa has 
demonstrated a very good performance during the assessment period with important contributions to the 
field. Highlights of the research include the design of polymeric hybrid systems which respond to external 
triggers and nanoparticulate delivery of DNA. The overlap for life sciences and related applications can 
still be increased with the polymer topics concerning bioconjugates etc. Whilst there was some evidence 
of publications in high impact journals, this aspect of the dissemination of research findings at the highest 
level should be addressed by the RC, and it is evident from the submitted evaluation material that this is 
an action in progress by the RC. 
Future plans which propose directing research to aid in building nanoparticle discovery pipelines are 
exciting yet realistic given the expertise within the RC, although attention should be given to establishing 
collaborative procedures to take forward leading candidate systems to animal or even clinical testing. The 
RC may also wish to consider opportunities to source new actives from RCs in UH or other centres in 
Finland. 
Overall, the RC is at a high level nationally and performing well at the international level. With a proven 
quality track record over the evaluation period, the RC has a well thought out research strategy and 
potential for continuing success and progress in the future. 
Numeric evaluation: 3 (Very good) 
2.2 Practises and quality of doctoral training 
 Organising of the doctoral training in the RC. Description of the RC’s principles for: 
 recruitment and selection of doctoral candidates 
 supervision of doctoral candidates 
 collaboration with faculties, departments/institutes, and potential graduate schools/doctoral 
programmes 
 good practises and quality assurance in doctoral training 
 assuring of good career perspectives for the doctoral candidates/fresh doctorates 
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 Identification of the RC’s strengths and challenges related to the practises and quality of doctoral 
training, and the actions planned for their development. 
 Additional material: TUHAT compilation of the RC’s other scientific activities/supervision of doctoral 
dissertations 
ASPECTS: Processes and good practices related to leadership and management 
 
The procedures of the doctoral training programmes indicate a well structured and coordinated process 
with high quality supervisory systems in place, covering all aspects from student recruitment to thesis 
defence. The international positioning of the RC is confirmed by the fact that 40% of the academic 
researchers are from outside of Finland. With 14 staff acting as supervisors for a current cohort of 32 
doctoral students, the detailed requirements placed on students to achieve a high level of critical appraisal 
of their work, and the need to obtain 60 ECTS points, the quality of the programme is evident. The 
increased attention to publish full reports in high quality journals is both important and challenging but 
appropriate to the fields of study in this RC. The infrastructure for doctoral training is augmented by 
numerous collaborations within and without the Department of Chemistry and Faculty of Pharmacy, 
broadening the experience of the doctoral candidates. 
The career progression and employment of doctoral graduates has been excellent with the extensive 
national and international contacts and collaborations of RC staff facilitating opportunities. 
Plans to encourage additional multidisciplinarity in doctoral supervisory panels should be carried out. 
The time needed for the teaching workload should be considered. The challenge highlighted by the RC in 
completing 4–5 quality publications by doctoral candidates in a 4 year programme for the current PhD 
thesis format is recognised, and perhaps this issue could be raised and discussed more widely as this issue 
will not be exclusive to this RC. A flexible and quality oriented evaluation would be better than a strictly 
quantitative oriented one. 
Numeric evaluation: 4 (Excellent) 
2.3 The societal impact of research and doctoral training 
 Description on how the RC interacts with and contributes to the society (collaboration with public, 
private and/or 3rd sector). 
 Identification of the ways to strengthen the societal impact of the RC’s research and doctoral training. 
 Additional material: TUHAT compilation of the RC’s other scientific activities. 
ASPECTS: Societal impact, national and international collaboration, innovativeness 
 
The research topics of DePoNa have major impact on society, especially with regard to the design of 
efficient and efficacious medicine for several areas of unmet clinical need. The education of the public is 
another significant area of societal impact. Recognized contributions of the RC include conference 
presentations, duties for journal work, organization of conferences and membership of professional and 
scientific committees at both national and international levels. Other excellent work with the media for the 
wider public has also been performed. 
Importantly the RC has a wide number of interactions and collaborations with the national and 
international sectors of the pharmaceutical and biopharmaceutical industry. With over 20 patents and 
patent applications, and one invention linked to a current application for regulatory approval for a 
medicine, the vitality and innovative potential of the discoveries from the RC and their value to the 
community are demonstrated. These successes are excellent and most impressive. 
As a result, the RC is recruiting a research manager to market the available expertise and innovations 
and encourage links to CROs to evaluate the drug delivery systems in cell models. With continuing 
progress, the RC may wish to reflect on preparing a route to taking leading candidate formulations to 
animal and clinical studies. 
Numeric evaluation: 5 (Outstanding) 
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2.4 International and national (incl. intersectoral) research 
collaboration and researcher mobility 
 Description of  
 the RC’s research collaborations and joint doctoral training activities 
 how the RC has promoted researcher mobility 
 Identification of the RC’s strengths and challenges related to research collaboration and researcher 
mobility, and the actions planned for their development. 
ASPECTS: Scientific quality, national and international collaboration 
 
Almost all the publications from DePoNa involve external collaboration, with impressively over 65% 
international collaborators. With an international group of academic researchers working in the RC, and 
long term visits by overseas researchers funded by foreign agencies, a strong culture of external 
collaboration is embedded in the philosophy of the RC. This aspect is reinforced through extensive 
national collaboration within the UH and other academic centres in Finland. The international collaboration 
network will be further enhanced if the current application for CoE status is approved. The good contact to 
industry and the increased exchange with regulatory administrations in health organisations is highlighted 
and should be kept/further increased. 
The mobility of home RC researchers abroad is stated to be less than external visitors, and this 
situation should be addressed, and encouragement should be given to improve the international 
experience of home doctoral students and research staff. Extensive international contacts and 
collaborations are in place and could be exploited in this task. An initiative for an EU-grant under the 
leadership of the RC members may increase the international visibility. 
Numeric evaluation: 4 (Excellent) 
2.5 Operational conditions 
 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties). 
 Identification of the RC’s strengths and challenges related to operational conditions, and the actions 
planned for their development. 
ASPECTS: Processes and good practices related to leadership and management 
 
Research infrastructure is very good and sound. Whilst the maintenance and renewing of expensive 
equipment remains a continuous challenge, recent grant successes have helped. Several core facilities not 
available within the RC are located in Helsinki, Aalto and Tampere Universities in Finland and Trieste 
University in Italy and are important, and links need to be carefully managed. 
Teaching loads are not limiting research and are regarded as a positive input for preparing high quality 
new doctoral students. This positive attitude and forward look is encouraging to hear. 
As will be the case for other RCs, basic funding needs to be supplemented via grant income to maintain 
a high quality, internationally leading research effort. Much researcher’s time is spent on this task in 
preparing and submitting grant applications and is seen as a challenge. One option the RC might consider 
is the recruitment of a grants coordinator to project to manage this widespread effort, with the possibility 
of this post being shared across several RCs who have a similar challenge. 
The need for a protein engineering unit may be faced at first instance by cooperation with other RCs 
(e.g. PhaBio) which have larger biotechnology facilities installed. The same may be true for other needs 
which may be covered by accessing other high quality facilities at UH in the same way. 
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2.6 Leadership and management in the researcher community 
 Description of  
 the execution and processes of leadership in the RC 
 how the management-related responsibilities and roles are distributed in the RC 
 how the leadership- and management-related processes support 
 high quality research 
 collaboration between principal investigators and other researchers in the RC 
 the RC’s research focus 
 strengthening of the RC’s know-how 
 Identification of the RC’s strengths and challenges related to leadership and management, and the 
actions planned for developing the processes 
ASPECTS: Processes and good practices related to leadership and management 
 
The organizational structure appears adequate and the RC is searching for optimal operation. The 
appointment of the research manager can be expected to improve the logistics. This may especially be 
true since it is one of the larger RC within UH and since external funding is essential to maintain the high 
level of research. 
2.7 External competitive funding of the RC 
• The RCs were asked to provide information of such external competitive funding, where: 
• the funding decisions have been made during 1.1.2005–31.12.2010, and  
• the administrator of the funding is/has been the University of Helsinki 
• On the e-form the RCs were asked to provide: 
1) The relevant funding source(s) from a given list (Academy of Finland/Research Council, 
TEKES/The Finnish Funding Agency for Technology and Innovation, EU, ERC, foundations, other 
national funding organisations, other international funding organizations), and 
2) The total sum of funding which the organisation in question had decided to allocate to the RCs 
members during 1.1.2005–31.12.2010. 
Competitive funding reported in the text is also to be considered when evaluating this point. 
ASPECTS: Scientific quality, scientific significance, societal impact, innovativeness and future significance 
 
The total funding from national and international sources over the assessment period was over €13m, 
which is an extremely commendable amount, and the RC should be congratulated on securing this level of 
funding. A number of agencies awarded major sums – the Academy of Finland, TEKES, EU – which 
demonstrates a positive breadth of external support for the RC from both academic and 
industrial/technical grant agencies, a positive feature. 
EU grants and leadership should be envisaged within the future plans. 
2.8 The RC’s strategic action plan for 2011–2013 
• RC’s description of their future perspectives in relation to research and doctoral training. 
ASPECTS: Scientific quality, scientific significance, societal Impact, processes and good practices related to 
leadership and management, national and international collaboration, innovativeness, future significance 
 
The planning and future perspectives with regard to research and doctoral training have been highlighted 
in part in sections 2.1–2.7 above. These are well considered and ambitious, yet achievable, for this RC. 
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2.9 Evaluation of the category of the RC in the context of entity of 
the evaluation material (1-8) 
The RC’s fitness to the chosen participation category. 
Category 1. The research of the participating community represents the international cutting edge in its field. 
 
From the information and evidence provided in the evaluation material with regard to the quality of 
research and doctoral training, the Panel were of the view that a more appropriate participation category 
for the RC at this stage of its development would be participation category 2: The research of the 
participating community is of high quality, but the community in its present composition has yet to 
achieve strong international recognition or a clear break-through. The attention clearly being given by the 
RC to publish more of their research findings in leading, high impact journals, and success in this activity 
will undoubtedly add value to the growing strength and recognized quality of the RC. 
Numeric evaluation: 3 (Very good) 
2.10 Short description of how the RC members contributed the 
compilation of the stage 2 material 
Appropriate and fair, with comments sought from all RC personnel before final compilation. 
2.11 How the UH’s focus areas are presented in the RC’s research 
Focus area 5: Welfare and safety 
 
The RC has selected UH focus area 5 – Welfare and safety. This is totally appropriate and relevant to the 
fields of research and training being performed by this RC. 
2.12 RC-specific main recommendations 
The RC is clearly working in areas of importance in creating knowledge in the fields of drug delivery 
science and polymer-based nanotechnology. The Panel, encouraged to see the evidence of success in 
research and in particular the doctoral training provided by the RC, were supportive of the approach being 
adopted to focus further attention on the publication strategy when disseminating the outcomes of their 
work. Success in this activity is important in achieving a stronger reputation and standing for the RC. 
The contributions to societal impact of the research and doctoral training were thought to be especially 
impressive, particularly from the evidence of numerous patents and the advanced stage of application of 
several of the inventions in commercial uptake. Given the increasing attention of the RC to bringing 
forward new drug delivery systems and nanobased systems, a recommendation is that the RC considers 
identifying partners, possibly existing within the UH, to continue studies on their prototype systems to the 
next steps in the value chain. Access to both animal and even clinical facilities would provide an exciting 
and potentially valuable resource. 
2.13 RC-specific conclusions 
The RC has, over the evaluation period, operated successfully in a multidisciplinary dimension between 
three centres. Such breadth and cooperativeness is essential in making strong impact in the topics and 
areas of research being undertaken by the RC. The Panel were most encouraged to note the research 
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successes of the RC, particularly in the aspects of their doctoral training programme and the contributions 
made to societal impact. Especially important is the strategy being implemented by the RC to address the 
need for publication of the outputs of their research in high impact journals, which will strengthen their 
reputation and standing and be increasingly recognized at the highest levels. 
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3 Appendices 
A. Original evaluation material 
a. Registration material – Stage 1 
b. Answers to evaluation questions – Stage 2 
c. List of publications 
d. List of other scientific activities 
B. Bibliometric analyses 
a. Analysis provided by CWTS/University of Leiden 
b. Analysis provided by Helsinki University Library (66 RCs) 
 
 
 
 
 
International evaluation of research and doctoral training 
at the University of Helsinki 2005-2010 
 
         RC-SPECIFIC MATERIAL FOR THE PEER REVIEW 
 
 
 
 
NAME OF THE RESEARCHER COMMUNITY:  
Drug Delivery and Polymer Based Nanotechnology (DePoNa) 
 
LEADER OF THE RESEARCHER COMMUNITY:  
Professor Arto Urtti, Faculty of Pharmacy, Centre for Drug Research 
 
 
RC-SPECIFIC MATERIAL FOR THE PEER REVIEW: 
 Material submitted by the RC at stages 1 and 2 of the evaluation 
- STAGE 1 material: RC’s registration form (incl. list of RC participants in an excel table) 
- STAGE 2 material: RC’s answers to evaluation questions 
 TUHAT compilations of the RC members’ publications 1.1.2005-31.12.2010 
 TUHAT compilations of the RC members’ other scientific activities 1.1.2005-31.12.2010 
 Web of Science(WoS)-based bibliometrics of the RC’s publications data 1.1.2005-31.12.2010 
(analysis carried out by CWTS, Leiden University) 
NB! Since Web of Science(WoS)-based bibliometrics does not provide representative results for most RCs representing 
humanities, social sciences and computer sciences, the publications of these RCs will be analyzed by the UH Library 
(results available by the end of June, 2011) 
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INTERNATIONAL EVALUATION OF RESEARCH AND DOCTORAL TRAINING AT THE 
UNIVERSITY OF HELSINKI  
 
RC-SPECIFIC STAGE 1 MATERIAL (registration form) 
 
 
 
 
Name: Urtti, Arto 
E-mail:  
Phone: 0405402279 
Affiliation: Centre for Drug Research 
Street address: Viikinkaari 5 E, Helsinki 
 
 
Name of the participating RC (max. 30 characters): Drug Delivery and Polymer Based Nanotechnology 
Acronym for the participating RC (max. 10 characters): DePoNa 
Description of the operational basis in 2005-2010 (eg. research collaboration, joint doctoral training 
activities) on which the RC was formed (MAX. 2200 characters with spaces): Drug delivery is an 
increasingly important part of drug discovery and development, since improved drug delivery systems are 
needed to foster the development of improved medical treatments. Delivery issues are particularly critical 
in the delivery of biotechnological drugs (such as genes, siRNA, proteins), drugs with difficult target sites 
(retina, brain, tumours), and drugs with serious adverse effects (anti-cancer drugs). Polymers capable of 
forming defined nanostructures offer versatile possibilities to improve drug and gene delivery, cell therapy 
and cell model development for biopharmaceutics.  Successful research and doctoral education in this 
applied field of science requires multidisciplinary research environment.  This RC combines research and 
doctoral education programmes at Centre for Drug Research (Arto Urtti), Division of Biopharmacy and 
Pharmacokinetics (Marjo Yliperttula), and Laboratory of Polymer Chemistry (Heikki Tenhu) to provide 
adequate spectrum of methods and expertise that is needed for successful research and graduate 
education programme in drug delivery and polymer-based nanotechnology.  The RC encompasses expertise 
and infrastructures in biopharmaceutics, polymer synthesis and characterisation, self-assembly of 
polymeric nanostructures, protein engineering, molecular and cell biology, bioactivity screening, 
computational modeling, and imaging.  RC groups have substantial track record of collaboration in research 
and doctoral training. The RC is a part of a larger consortium that was selected to the final stage in the 
national call for Centres of Excellence in 2010 (application pending, to be decided by Academy of Finland in 
June 2011).  That consortium, Finnish Centre of Excellence in Pharmaceutical Nanotechnology (led by Arto 
Urtti), includes also Macromolecular Structure and Assembly group (Sarah Butcher, Institute of 
Biotechnology, University of Helsinki) and High Throughput Biology group (VTT Medical Biotechnology, 
Roland Grafström). In the coming years the research activity of the RC will be mostly focused around the 
CoE theme. 
 
 
Main scientific field of the RC’s research: medicine, biomedicine and healt sciences 
1 RESPONSIBLE PERSON 
2 DESCRIPTION OF THE PARTICIPATING RESEARCHER COMMUNITY (RC) 
3 SCIENTIFIC FIELDS OF THE RC 
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INTERNATIONAL EVALUATION OF RESEARCH AND DOCTORAL TRAINING AT THE 
UNIVERSITY OF HELSINKI  
 
RC-SPECIFIC STAGE 1 MATERIAL (registration form) 
 
 
RC's scientific subfield 1: Pharmacology and Pharmacy 
RC's scientific subfield 2: Nanoscience and Nanotechnology 
RC's scientific subfield 3: Materials Science, Biomaterials 
RC's scientific subfield 4: Chemistry, Applied 
Other, if not in the list: polymer science, eye research 
 
 
Participation category: 1. Research of the participating community represents the international cutting 
edge in its field 
Justification for the selected participation category (MAX. 2200 characters with spaces):  Drug delivery is 
an increasingly important part of drug discovery and development, since improved drug delivery systems 
are needed to foster the development of improved medical treatments. Delivery issues are particularly 
critical in the delivery of biotechnological drugs (such as genes, siRNA, proteins), drugs with difficult target 
sites (retina, brain, tumours), and drugs with serious adverse effects (anti-cancer drugs). Polymers capable 
of forming defined nanostructures offer versatile possibilities to improve drug and gene delivery, cell 
therapy and cell model development for biopharmaceutics.  Successful research and doctoral education in 
this applied field of science requires multidisciplinary research environment.  This RC combines research 
and doctoral education programmes at Centre for Drug Research (Arto Urtti), Division of Biopharmacy and 
Pharmacokinetics (Marjo Yliperttula), and Laboratory of Polymer Chemistry (Heikki Tenhu) to provide 
adequate spectrum of methods and expertise that is needed for successful research and graduate 
education programme in drug delivery and polymer-based nanotechnology.  The RC encompasses expertise 
and infrastructures in biopharmaceutics, polymer synthesis and characterisation, self-assembly of 
polymeric nanostructures, protein engineering, molecular and cell biology, bioactivity screening, 
computational modeling, and imaging.  RC groups have substantial track record of collaboration in research 
and doctoral training. The RC is a part of a larger consortium that was selected to the final stage in the 
national call for Centres of Excellence in 2010 (application pending, to be decided by Academy of Finland in 
June 2011).  That consortium, Finnish Centre of Excellence in Pharmaceutical Nanotechnology (led by Arto 
Urtti), includes also Macromolecular Structure and Assembly group (Sarah Butcher, Institute of 
Biotechnology, University of Helsinki) and High Throughput Biology group (VTT Medical Biotechnology, 
Roland Grafström). In the coming years the research activity of the RC will be mostly focused around the 
CoE theme. 
 
 
Public description of the RC's research and doctoral training (MAX. 2200 characters with spaces): This RC 
is a multidisciplinary consortium that carries out cutting edge research in the fields of drug delivery and 
polymer-based nanotechnology. Polymer chemistry is the key scientific discpline in the development of 
nanostructures for technological and medical uses. Laboratory of Polymer Chemistry is highly qualified unit 
in the design, synthesis and characterisation of self-assembling polymers and their nanoassemblies. Centre 
for Drug Research has specialised in drug discovery tools, drug delivery and pharmaceutical 
nanotechnology. Division of Biopharmacy and Pharmacokinetics has expertise in nanotechnology, surface 
4 RC'S PARTICIPATION CATEGORY 
5 DESCRIPTION OF THE RC'S RESEARCH AND DOCTORAL TRAINING 
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INTERNATIONAL EVALUATION OF RESEARCH AND DOCTORAL TRAINING AT THE 
UNIVERSITY OF HELSINKI  
 
RC-SPECIFIC STAGE 1 MATERIAL (registration form) 
 
 
chemistry, and pharmacokinetics. Combined research in the RC generates versatile spectrum of expertise, 
skills and infrastructure that will foster the multidisciplinary research and doctoral education in the central 
fields of drug delivery and polymer-based nanotechnology. The research work of RC informs about the 
polymeric nanostructures and drug delivery in various ways ranging from physical and chemical properties 
to the cell biology and in vivo pharmacokinetics. The RC aims to generate new understanding of  platform 
for hybrid nanomaterials for drug delivery. This is an important goal, since shortcomings in drug delivery 
are hampering the development of new treatments based on biotechnological drugs, and on delivery into 
the retina, brain and tumours.  Doctoral training in this international and multidisciplinary RC helps 
students acquire skills and expertise at the interface of the disciplines, an important asset for their later 
career in the academia, industry and regulatory organisations.  It is noteworthy that several level members 
of the RC at career levels of III and IV have also long and relevant industrial experience. 
Significance of the RC's research and doctoral training for the University of Helsinki (MAX. 2200 
characters with spaces): The RC is strategically important for the University of Helsinki. Biomedical science 
is in the phase of major changes. Human genome has been sequenced, chemical biology platforms inform 
about the biological effects of the chemical structures, high thoughput methods reveal mechanisms of 
diseases, and new therapeutic modalities, such as gene silencing RNA provide avenues towards new 
treatments. UH is one of the leading biomedical Universities in Europe, but translation of the recent 
advances towards therapeutic applications is often hampered by the problems of drug delivery. 
International level group in drug delivery and drug discovery tools has important strategic role in bridging 
the advances of basic science towards the applications.  Polymer science, imaging, modeling and many 
other technologies of this RC are needed to fulfill this task.  Laboratory of Polymer Chemistry is strategically 
as important, because nanotechnology is one of the major international trends in science and technology. 
In EU-FP programmes nanotechnology is one the main fields of funding.  Polymer chemistry, particularly 
self-assembling polymeric nanostructures, is a key area of nanotechnology.  Therefore, strong polymer 
chemistry research and doctoral education is critically important for UH in the era of nanotechnology. In 
this RC bioinspired approaches, like protein engineering, biomolecule conjugation, and virus inspired 
approaches, are combined with synthetic polymer chemistry to generate new functionalities at the 
interface of chemistry and biology. Furthermore, drug delivery is one of the most appealing applications of 
polymer-based nanotechnology. The RC is closely and broadly linked to the Finnish scientific and industrial 
community, including Biocenter Finland, network of key core laboratories. The RC is involved in the core 
laboratories in ”Drug Discovery and Chemical Biology” and ”Stem Cells and Biomaterials”.   Centre for Drug 
Research is has important strategic importance in the Faculty of Pharmacy, and the focus of the RC is in line 
with the focus areas of the Faculty. 
Keywords: Drug delivery, biopharmaceutics, drug formulation, polymer chemistry, nanoparticle, 
biomaterial 
 
 
Justified estimate of the quality of the RC's research and doctoral training at national and international 
level during 2005-2010 (MAX. 2200 characters with spaces): Research. RC is carrying out cutting edge 
research in its fields. Nationally the success is evidenced by the fact that Laboratory of Polymer Chemistry is 
part of Finnish Center of Excellence in Functional Materials, since 2008.  Application for CoE in 
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Pharmaceutical Nanotechnology was the only pharmaceutical or pharmacological CoE application that was 
selected to the final round from the 1st stage of evaluation. International position of the RC during 2005-
2010 is evidenced by publication activity (about 150), international expert duties, invited presentations, 
citations (> 5000), and five EU grants.   
 
Doctoral education. The RC has been an recognized international training site and partner in doctoral 
education (EU Marie Curie EST training grant GALENOS; GPEN Network Member). The graduated Ph.D. 
students have obtained good positions and many of them have successfully continued the career in 
science.  The RC is also attracting foreign students and it provides modern and multidicsciplinary learning 
environment.  
 
TIme perspective. It should be noted that many PIs in the RC started at University of Helsinki in 2005 or 
later. The RC is relatively new and in fast progress. 
Comments on how the RC's scientific productivity and doctoral training should be evaluated (MAX. 2200 
characters with spaces): Suggestions. It is important that the panel has broad and top-level expertise that 
spans the spectrum of this multidisciplinary RC. We hope that the panel will give useful advice about the 
following aspects: 1) Quality of publications in 2005-2010. Are they at the cutting edge of the field ? Are 
there research topics that should be discontinued or missing aspects ? 2) Are infrastructure and personnel 
well planned ? 3) Comments about the international competitiveness and visibility. 4) Assess the quality of 
the doctoral training. What elements are missing ? 5) Work plan. The RC will increase the collaboration 
substantially in 2011 and onwards within the framework of the CoE application. Critical assessment of the 
plan is important, since we would like to benefit maximally from the consortium of the CoE application. 
Publication strategy. The RC prefers to publish large reports including multiple methods, often ranging from 
physical chemical studies to cell biological experiments.  Preferable forums are the leading journals in the 
relevant fields of science. The strategy is demanding, but it is worthwhile for many reasons: 1) Drug 
delivery systems, cell models and transport processes are not ‘isolated’ systems defined by a single 
parameter. Rather, they must be assessed rigorously. We are not selling our research and technologies, but 
rather we want to investigate them carefully to obtain reliable information that lays basis for the future 
drug development. 2) Polymer synthesis and characterisation of the self-assembling nanostructures are 
demanding tasks. Careful and versatile material characterisation is critically important.  3) Self-critical 
publishing approach strategy provides healthy basis for the doctoral training. The doctoral students acquire 
methological expertise, skills enabling them to operate in different positions, including ability to discuss 
with people from many disciplines, a feature that we consider very important in modern research and 
development in the fields of pharmaceutics and polymer science. 
LIST OF RC MEMBERS
NAME OF THE RESEARCHER COMMUNITY: DRUG DELIVERY AND POLYMER BASED NANOTECHNOLOGY (DePoNa)
RC-LEADER A. Urtti
CATEGORY 1
Last name First name
PI-status 
(TUHAT, 
29.11.2010)
Title of research and 
teaching personnel Affiliation 
1 Urtti Arto x professor Centre for Drug Research
2 Antopolsky Maxim post doctoral researcher Centre for Drug Research
3 Häkli Marika post doctoral researcher Centre for Drug Research
4 Tammela Päivi x university researcher Centre for Drug Research
5 Murtomäki Lasse x university researcher Centre for Drug Research
6 Bergstrom Kim x university researcher Centre for Drug Research
7 Laukkanen Antti post doctoral researcher Centre for Drug Research
8 Kidron Heidi post doctoral researcher Centre for Drug Research
9 Raki Mari post doctoral researcher Centre for Drug Research
10 Sarkhel Sanjay Senior researcher Centre for Drug Research
11 Takashima Yuuki professor Centre for Drug Research
12 Ravina Manuela post doctoral researcher Centre for Drug Research
13 Hornof Margit post doctoral researcher Centre for Drug Research
14 del Amo Eva doctoral candidate Centre for Drug Research
15 Lehtinen Julia doctoral candidate Centre for Drug Research
16 Subrizi Astrid doctoral candidate Centre for Drug Research
17 Vellonen Kati-Sisko doctoral candidate Centre for Drug Research
18 Kontturi Leena doctoral candidate Centre for Drug Research
19 Schmitt Metchild doctoral candidate Centre for Drug Research
20 Linnankoski Johanna doctoral candidate Centre for Drug Research
21 Malinen Melina doctoral candidate Centre for Drug Research
22 Paasonen Lauri doctoral candidate Centre for Drug Research
23 Kotha Sreevani doctoral candidate Centre for Drug Research
24 Yamada Kazuhito doctoral candidate Centre for Drug Research
25 Lajunen Tatu doctoral candidate Centre for Drug Research
26 Wang Chang-Fang doctoral candidate Centre for Drug Research
27 Bhattacharya Madhuashree post doctoral researcher
Centre for Drug Research / Division of Biopharmacy 
and Pharmacokinetics
28 Tenhu Heikki x Professor
HU, Department of Chemistry, Laboratory of 
Polymer Chemistry
29 Aseyev Vladimir x University lecturer
HU, Department of Chemistry, Laboratory of 
Polymer Chemistry
30 Hietala Sami x University lecturer
HU, Department of Chemistry, Laboratory of 
Polymer Chemistry
31 Plamper Felix Postdoctoral Researcher
HU, Department of Chemistry, Laboratory of 
Polymer Chemistry
32 Zarembo Anna Postdoctoral Researcher
HU, Department of Chemistry, Laboratory of 
Polymer Chemistry
33 Holappa Susanna Doctoral Candidate
HU, Department of Chemistry, Laboratory of 
Polymer Chemistry
34 Nuopponen Markus Doctoral Candidate
HU, Department of Chemistry, Laboratory of 
Polymer Chemistry
35 Hirvonen Sami-Pekka Doctoral Candidate
HU, Department of Chemistry, Laboratory of 
Polymer Chemistry
36 Karesoja Mikko Doctoral Candidate
HU, Department of Chemistry, Laboratory of 
Polymer Chemistry
37 Karjalainen Erno Doctoral Candidate
HU, Department of Chemistry, Laboratory of 
Polymer Chemistry
38 Alhoranta Anu Doctoral Candidate
HU, Department of Chemistry, Laboratory of 
Polymer Chemistry
39 Larin Sergey Doctoral Candidate
HU, Department of Chemistry, Laboratory of 
Polymer Chemistry
40 Niskanen Jukka-Pekka Doctoral Candidate
HU, Department of Chemistry, Laboratory of 
Polymer Chemistry
41 Pulkkinen Petri Doctoral Candidate
HU, Department of Chemistry, Laboratory of 
Polymer Chemistry
42 Valtola Lauri Doctoral Candidate
HU, Department of Chemistry, Laboratory of 
Polymer Chemistry
43 Wiktorowicz Szymon Doctoral Candidate
HU, Department of Chemistry, Laboratory of 
Polymer Chemistry
44 Yliperttula Marjo x Professor Division of Biopharmacy and Pharmacokinetics
45 Viitala Tapani Senior researcher Division of Biopharmacy and Pharmacokinetics
46 Kortejärvi Hanna post doctoral researcher Division of Biopharmacy and Pharmacokinetics
47 Lu Yan-Ru post doctoral researcher Division of Biopharmacy and Pharmacokinetics
48 Kallinteri Paraskevi post doctoral researcher Division of Biopharmacy and Pharmacokinetics
49 Wikström Jonna doctoral candidate Division of Biopharmacy and Pharmacokinetics
50 Hanzlikova Martina doctoral candidate Division of Biopharmacy and Pharmacokinetics
51 Granqvist Niko doctoral candidate Division of Biopharmacy and Pharmacokinetics
52 Galli Emilia doctoral candidate Division of Biopharmacy and Pharmacokinetics
53 Polina Ilina doctoral candidate Division of Biopharmacy and Pharmacokinetics
54 Huamin Liang doctoral candidate Division of Biopharmacy and Pharmacokinetics
55 Tengvall Unni doctoral candidate Division of Biopharmacy and Pharmacokinetics
56 Marvola Janne doctoral candidate Division of Biopharmacy and Pharmacokinetics
57 Laitinen Leena doctoral candidate
Division of Biopharmacy and 
Pharmacokinetics/Centre for Drug Research
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Name of the RC’s responsible person: Urtti, Arto 
E-mail of the RC’s responsible person:   
Name and acronym of the participating RC: Drug Delivery and Polymer-Based Nanotechnology, DePoNa 
The RC’s research represents the following key focus area of UH: 5. Hyvinvointi ja turvallisuus – Welfare 
and safety 
Comments for selecting/not selecting the key focus area: RC is working on polymer based drug delivery, 
an important part of drug discovery and development.  Pharmaceuticals are one of the main components in 
the treatment of diseases. Thus it is obvious that the RC is working in the field of welfare. Health is the 
most important component of human welfare.  The RC is also linked to the basic structure, materials and 
natural resources of the physical world.  The investigations of the RC inform about the nanoscale structures 
and principles of their formation. 
 
 
 Description of the RC’s research focus, the quality of the RC’s research (incl. key research 
questions and results) and the scientific significance of the RC’s research for the research 
field(s).  
RESEARCH FOCUS. This RC is a multidisciplinary consortium that carries out research in the fields of drug 
delivery and polymer-based nanotechnology. The RC consists of research groups from Laboratory of 
Polymer Chemistry, Centre for Drug Research and Division of Biopharmacy and Pharmacokinetics. The 
research of RC in 2005-2010 has informed about the polymeric nanostructures (synthesis, 
characterisation, modeling, nanoassemblies, drug and gene delivery properties) and about the tools for 
drug discovery and delivery (computational, physical , cellular and in vivo imaging methods). The 
delivery targets have included the eye, skin, tumours, and microbes.  
 
Even though polymer chemistry laboratory and pharmaceutical groups have had collaboration for 
several years, the integration of the groups into the RC is still fairly new development. Many PIs within 
the RC joined University of Helsinki recently, during the period 2005-2010 (Arto Urtti, Marjo Yliperttula, 
Kim Bergström, Lasse Murtomäki). The RC aims to focus and integrate its activities further in order to 
generate new materials, understanding and analytical methods for the field of nanotechnological drug 
delivery. This is an important goal, since shortcomings in drug delivery are limiting the development of 
new drug treatments. 
 
QUALITY. Several factors indicate that the research of the RC is at the forefront internationally. 1) The 
RC is part of ”Finnish Center of Excellence (CoE) in Functional Materials” (2008-); 2) The first stage 
application ”Finnish CoE in Pharmaceutical Nanotechnology” received maximum rating (6/6 twice; 
top1% in its field) and was selected to the 2nd stage evaluation (will be completed in June 2011); 3) The 
RC publications were cited more than 5000 times in 2005-2010; 6); 4) The RC has raised successfully 
funding from European Union and other national and international sources; 5) During 2005-2010 the RC 
published about 150 publications, mostly in the leading journals of its fields; 6) Centre for Drug Research 
and Laboratory of Polymer Chemistry received previously excellent international evaluations (2006, 
2010, 2011); 7) Group leaders have received awards, hold international expert duties (editor-in-chief, 
editorial advisory board positions) and serve as experts in several international funding organisations; 8) 
The RC laboratories have attracted large number of foreign investigators.  
BACKGROUND INFORMATION 
1 FOCUS AND QUALITY OF RC'S RESEARCH (MAX. 8800 CHARACTERS WITH SPACES) 
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The research of the RC resulted in important basic science findings in the fields of polymeric 
nanostructures (defined novel copolymers, metal-polymer hybrids, metal-lipid nanostructures, DNA-
polymer complexes) and barriers and processes affecting drug transport in the eye, skin, intestine and, 
inside cells. Applied research involved investigations on tailored smart nanomaterials (responsive to 
light, electricity, temperature), materials for drug delivery (controlled release, cell encapsulation, 
intracellular delivery), and methods for drug discovery and delivery (computational, cell models, 
screening assays).  
 
Examples  
1) Self-assembling amphiphilic and/or water soluble polymers including polyelectrolytes have been 
synthesised using modern methods of controlled radical polymerisation. Of special interest have been 
responsive polymers which discontinuously change their conformation, shape, and solubility upon an 
external trigger. The trigger may be temperature, pH, ionic strength, light, or even electric field (Adv 
Polym Sci 196: 1, 2006, Macromolecules 42: 7254, 2009). Nanocomposites comprising inorganic core 
materials, such as gold (Chem Comm 44: 4580, 2007, Macromolecules 42: 5317, 2009), silver (Colloid 
Polym Sci 288: 543, 2010), or montmorillonite have been prepared. At present some of the topical 
research areas include star block copolymers (Polymer 51: 3108, 2010) and polymerised ionic liquids. 
Also, polyelectrolyte complexes have been actively studied. 
 
2) Nanoparticulate delivery of DNA. Nanoparticles based on complexation of cationic polymer and DNA 
are  potential delivery system in non-viral gene therapy. The efficacy of these nanoparticles in gene 
transfer does not match that of viruses, but the mechanisms of DNA complexation and delivery are still 
poorly understood. The RC revealed with a new time-resolved spectroscopy method that the mobility of 
DNA in nanoparticles varies depending on the complexing polymer (J Am Chem Soc 130: 11695-11700, 
2008) and this may explain our earlier findings that showing even 100 fold differences in transfection 
activity per DNA copy delivered to the cell nucleus (J Gene Med 9: 479-486, 2007). In vivo experiments 
with DNA nanoparticle eye drops demonstrate strategy to overcome the barrier of corneal epithelium 
by converting it protein secreting platform (J Gene Med 9: 208-216, 2007). 
 
3) Light activated hybrid nanoparticles for drug delivery.  Hybrid system of functionalised gold 
nanoparticles embedded in liposomes were developed. Proof-of-concept study showed that contents 
release was selectively triggered with light signal (J Control Rel 122: 86-93, 2007). Mechanistic study 
revealed that the gold absorbed the light energy, released it to the lipid bilayer as heat, and caused 
phase change in the bilayer (J Control Rel 147: 136-143, 2010).  
 
THE SCIENTIFIC SIGNIFICANCE 
The research work of the RC is significant and promotes the field of polymer based nanotechnology and 
drug delivery.  
 
1) Research on new polymers has revealed relationships between polymer structure and its assembly 
and triggered functions. This promotes understanding and generation of new materials. 
 
2) Organotypic cell models (particularly epidermal and RPE models) are useful tools for drug discovery 
and development.  Likewise, drug delivery related QSAR models (intestinal and ocular absorption) and 
kinetic models (oral and periocular administration) reveal important parameters in drug delivery.  
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3) Characterisation of transporter expression in the eye promotes understanding of the basic ocular 
pharmacokinetic mechanisms. 
 
4) Basic research on physical nanoparticle assembly and its intracellular transfer mechanisms build the 
basis for understanding the non-viral gene delivery. 
 
5) Research on nanoparticle carriers with triggered functions offer new drug development scenarios. 
 Ways to strengthen the focus and improve the quality of the RC’s research. 
Research quality will be improved by taking full advantage from the multidisciplinary expertise and 
infrastructure in the RC.  This will be done in the context of the CoE application that presents novel 
multidisciplinary approach to build nanoparticle discovery pipeline (see 8 ”Action plan”). Only closely 
integrated RC can achieve that goal.  Integration involves joint grants, laboratories, supervisions, and 
positions.   
 
Research at the chemistry – biology interface is a key element.  The multidiciplinary skills of the RC set 
the stage for polymer based bioconjugates (with peptides, proteins, oligonucleotides), that are 
important building tools in drug delivery.  
 
Importantly Francoise Winnik (professor of Polymer Chemistry and Pharmacy, University of Montreal) is 
willing to join the RC for several years as visiting FiDiPro professor.  Decision on this FiDiPro grant 
application (professor, 2 post docs and consumables) will be done by TEKES in the Spring 2011.  
 
The RC policy will be to publish less, but high publications. This policy guides the research towards 
higher quality. 
 
 
  How is doctoral training organised in the RC? Description of the RC’s principles for recruitment and 
selection of doctoral candidates, supervision of doctoral candidates, collaboration with faculties, 
departments/institutes, and potential graduate schools/doctoral programmes, good practises and 
quality assurance in doctoral training, and assuring good career perspectives for the doctoral 
candidates/fresh doctorates.  
Recruitment and selection. Doctoral candidates are selected using many mechanisms.  Some of them 
have been Master’s students in the RC and they are recruited based on their performance and 
motivation in the Master’s program, particularly during the M.Sc. thesis project.  Sometimes the 
doctoral candidates are selected based on open call (e.g. graduate schools).  Overall, the doctoral 
candidates in the RC are representing many scientific disciplines (e.g. biopharmaceutics, pharmaceutical 
technology, pharmacology, biochemistry, polymer chemistry, biotechnology) and origins (e.g. Finland, 
Switzerland, Czech Republic, Croatia, India, China, Russia, Italy, Spain).  International and 
multidisciplinary approach provides broader base of students for recruiting and matches with the 
multidisciplinarity requirements of modern pharmaceutical research. 
 
Supervision of doctoral candidates.  The doctoral education in this RC immensely benefits from the 
multidisciplinary nature of the RC. The doctoral candidates are exposed to the expertise in the following 
fields, all highly relevant in polymer based nanotechnology and drug delivery: polymer synthesis and 
characterisation, self-assembly and colloid chemistry, peptide and oligonucleotide synthesis, protein 
engineering, surface chemistry, physical chemistry, spectroscopy, molecular and cell biology, stem cell 
biology, biomaterial based organotypic cell culture, radiochemistry and imaging, bioactivity screening, 
2 PRACTISES AND QUALITY OF DOCTORAL TRAINING (MAX. 8800 CHARACTERS WITH SPACES) 
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pharmacokinetic modeling, chemoinformatics and molecular dynamics, biopharmaceutics and drug 
delivery.  The doctoral candidates develope skills of social communication in international surroundings 
when they are educated in the RC with personnel of 40% foreigners.  
 
Each doctoral candidate has two or more supervisors, in many cases from different research groups 
within the RC. The ratio of doctoral level researchers and graduate students is about ½. This facilitates 
hands-on supervision in the laboratory.  Regular supervision meetings are held, international research 
training visits are encouraged. The presentation skills of doctoral candidates are practised in regular 
laboratory meetings. Furthermore, the Ph.D. students apply for stipends that involves writing of the 
research proposals.  Importantly, the Ph.D. Theses are composed of publications and summary. Thus, 
the doctoral candidates learn to write publications and are exposed to the peer-review system of the 
journals.  In the normal way, the Ph.D. students must carry out program of 60 ECTS points during their 
doctoral studies. This program includes both compulsory and optional elements. The courses and book 
exams are compiled in multidisciplinary manner with the supervisors. 
 
Collaboration with faculties and departments. This multidisciplinary RC is operating in the Department 
of Chemistry and Faculty of Pharmacy.  The RC has been linked to several national graduate schools 
(Pharmaceutical Research, ESPOM, NANO) and utilises the courses organised by these networks.  The RC 
groups have plenty of research collaborations in the University of Helsinki, with other universities in 
Finland and elsewhere.  These collaborations have influence on the doctoral training, because the 
students are exposed to new research methods and viewpoints. 
 
Good practises and quality assurance in doctoral training.  High quality training of doctoral candidates 
should result in Ph.D. level researchers who have learned how good research is done, i.e. how to 
identify important questions, design experiments, analyse results, report the findings in objective and 
critical manner in the light of prior knowledge. In addition, the doctoral candidates should learn  
adequate breadth of methods.  Doctoral projects in the RC are demanding, since they involve usually 
broad selection of methods and challenging research problems. For example, a publication may involve 
generation of nanoparticles, physical and chemical characterisation, cell based experimentation and 
molecular biology methods, and finally in vivo testing and imaging in animals. Multidisciplinary RC is 
important asset in this context.  In the case of problems, broad range of experts are found within the 
same RC and the research can be modified in a flexible manner. Six Ph.D. students from RC groups have 
become successful professors. This shows quality of the education.  
 
Publishing the research in high level international journals is another quality assurance method.   
 
Doctoral candidates have a mid-term check point, defence of the research proposal.  The candidates 
must report their prior research and write a plan for the rest of the Ph.D. thesis project. The report and 
plan are discussed with three senior level researchers, representing usually different disciplines. The 
panel gives recommendations and critique to the student.  Critical evaluation of science is trained in the 
RC. The students read manuscripts that are submitted to the journals, evaluate them critically, and write 
the reviewer statement together with the supervisor.  
 
Assuring good career perspectives. Career perspectives for the graduating Ph.D.s in the RC are good.  
During 2005-2010 employment has been excellent. The doctors are employed easily both in academia 
and private sector.  Industrial projects and contacts of the RC help in the industrial employment. 
Likewise, the international contacts have made it easy to organise post-doctoral positions abroad.  
Obviously, there is need for doctors in pharmaceutical science and polymer chemistry. Upon integration 
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of the RC the employment should become even better as the doctoral candidates will get full benefit 
from the methodological wealth of the RC. 
 RC’s strengths and challenges related to the practises and quality of doctoral training, and the actions 
planned for their development. 
Strengths.  Multidisciplinary environment is the strength in the doctoral education.  Joint supervisions 
are ongoing and will be increased. Nano-bio fusion is expected to be highly important future trend; not 
only in drug delivery, but also in much broader scientific context. Employment is our strength.  
 
Challenges.  Sometimes the completion of Ph.D. degree takes too long.  Combination of challenging 
research, 4-5 high quality publications and four year Ph.D. program is a difficult combination.  Quality of 
research and doctoral education can be improved only by abandoning the 4-5 paper thesis format. 
Another improvement will be the integration of the RC activities and building a systematic Ph.D. 
program for the RC (chemistry, nanotechnology, biopharmaceutics interface).  Other future 
improvements include industrial and regulatory training periods for Ph.D. students. 
 
 
 
 Description of how the RC interacts with and contributes to the society (collaboration with public, 
private and/or 3rd sector).  
Education of experts to the public and private sectors is the main societal impact of the RC.   
 
Public sector.  
In the public sector the RC is providing services to scientific community. These include many duties of 
editor, editorial board member, and referee in scientific journals.  In addition, the RC members have 
been active in organizing scientific conferences, evaluating research proposals for national and 
international funding organisations, and as members of research councils in Academy of Finland.  The RC 
members have informed the public about the fields of pharmaceutical science and polymer chemistry.  
The instruments include public lectures, lectures to school kids, and interviews in magazines, radio and 
TV.  The work of the RC is also related to the development of alternatives to animal testing (such as 
organotypic cell culture models and computer models).  The RC is part of Biocenter Finland networks 
”Stem Cells and Biomaterials” and ”Drug Discovery and Chemical Biology”. The RC offers services to the 
academic community via these networks in the fields of bioactivity screening, chemoinformatics, 
ADMET and biomaterials for cell culture and gene transfer. 
 
Private sector. The RC has extensive industrial collaboration with chemical and pharmaceutical 
industries (see funding). The RC is collaborating with the industry also in the TEKES funded university 
projects with industrial observers.  Computational pharmacokinetic tools for prediction of drug delivery  
were developed in the RC and these tools are used now in a Finnish pharmaceutical company.  The RC 
has researcher exchange with industry, including also international pharmaceutical industry.  The RC 
members hold more than 20 patents and patent applications.  One of them is a polymer for controlled 
drug delivery that is in the final stages of the path towards regulatory acceptance. Another one is 
nanofiber biomaterial for 3D cell culture. This invention was patented and sold to industry. The RC is 
carrying out collaborative research with device company and pharmaceutical industry to develop 
innovative analytical technology and controlled release formulations.  It is noteworthy that several 
senior level researchers of the RC have long and relevant industrial experience and they have 
contributed to many products in the market. 
3 SOCIETAL IMPACT OF RESEARCH AND DOCTORAL TRAINING (MAX. 4400 CHARACTERS WITH SPACES) 
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 Ways to strengthen the societal impact of the RC’s research and doctoral training. 
Societal impact of the RC will be further improved.  Research manager will be hired to the Centre for 
Drug Research in the Summer 2011. He/she will market the expertise of the RC to the industry in Finland 
and abroad and carries out systematic patent searches. International industrial collaboration will be 
increased, and the RC will apply for IMI funding.  Nanomaterials and nanoparticles cause fears in the 
population and their toxicity has raised concerns.  Nanoparticle discovery pipeline (see #8) will produce 
systematic information about cellular toxicity of nanoparticles.  The RC will search contacts to the 
European Chemical Agency in Helsinki; the agency is resposible for the execution of REACH legislation on 
chemical safety.  The RC will actively link with CRO companies and service laboratories (such as FICAM), 
to transfer the cell models to real drug and chemical testing. Biocenter Finland activity will be continued 
and possibly evolved to EATRIS system. 
 
 
 
 Description of the RC’s research collaborations and joint doctoral training activities and how the RC 
has promoted researcher mobility.  
Research collaboration is essential for the RC.  Nearly all publications of the RC include either national 
and/or international collaborations.  About 50% of the publications include international collaboration. 
National collaborative projects are often based on TEKES projects (see funding) that always involve 
industrial collaboration. Several EU-FP projects of the RC facilitate international collaboration (see 
funding). Industrial collaboration has been very active (see funding).  About 40%  of the RC personnel 
are foreigners (e.g. from UK, Germany, The Netherlands, Switzerland, Spain, Italy, Russia, China, Japan, 
India, Portugal). There has been also some long-term visits funded by foreign funding agencies in Japan, 
Germany and Spain. In addition, there is also mobility as post docs from the RC to abroad, but actually 
this is less than the mobility to the RC. The RC supports and encourages short visits in association of 
research collaborations.   
 
International doctoral training activities include following networks: Marie Curie EST Galenos , GPEN, 
ESF network STIPOMAT. 
 
The RC has promoted the collaborations and researcher mobility financially (usually by grant funds) and 
by giving advice in fund raising.  The RC is not asking bench fee from foreign visiting researchers. 
 RC’s strengths and challenges related to research collaboration and researcher mobility, and the 
actions planned for their development. 
Strengths. 
It is obvious that the RC is already well linked. The academic collaborative links  nationally and 
internationally are excellent.  Particularly, the academic international network in the CoE application will 
be very fruitful for the research programme. Industrial networking in Finland is very good, but 
internationally not as extensive.  Possible FiDiPro visit (F. Winnik) would be an asset to the RC. 
 
Challenges. 
Mobility of the RC researchers to abroad should be steadily increased and co-supervision arrangements 
with international partners should be more intense. Interactions and collaboration with international 
industry should be increased (IMI important funding option).  We should also increase the use of www 
and social networks as tools in international communication. 
4 INTERNATIONAL AND NATIONAL (INCL. INTERSECTORAL) RESEARCH COLLABORATION AND RESEARCHER 
MOBILITY (MAX. 4400 CHARACTERS WITH SPACES) 
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 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties).  
RESEARCH INFRASTRUCTURE. In general the research infrastructure is good, but it is difficult to maintain 
and renew  the aging medium scale equipment. The RC has actively raised competitive funds for 
infrastructure. During 2005-2010 micro-SPECT/CT laboratory, array plotter, confocal high content 
analysis instrument, 500 MHz NMR, a zeta sizer, and circular dichroism instruments have been obtained.  
The RC is utilizing the shared use laboratories (core laboratories) in Helsinki and elsewhere.  Particularly 
important core laboratories include laboratories of Institute of Biotechnology (light microscopy unit, EM 
lab, proteomics laboratory, bioinformatics unit), Aalto University’s high resolution EM facility, laser 
spectroscopy laboratory of Tampere University of Technology, and ELETTRA beamline (SAXS) in Trieste.  
CSC provides the fast computing facilities to Finnish universities.  
 
Balance between research and teaching.  In the RC everybody contributes to both teaching and 
research. Overall, the teaching load is not limiting the research. The teaching tasks are shared, and the 
high level of external funding facilites teaching as well. Rather, teaching is excellent training of the 
doctoral candidates and post docs, and it attracts new students to the research programme.  
 
Overall laboratory space is adequate, but the laboratories of the pharmaceutical part of the RC are 
highly fragmented (in six different floors). This complicates the daily logistics.  
 
Basic funding of the RC would not allow research work.  The external grant funding level is very good. 
Often the funding policies are unpredictable, and the funding periods are fairly short (1-3 years). When 
individual grants are fairly small maintaining large research group means continuous grant applications 
and reporting.  This takes too much time, and disturbs concentrating on the science.  
 
Administrative support is variable. In some respects it is good, but often the administrative systems are 
complicated and inefficient.  Particularly, in 2010 the financial logistics of the grant funding became 
much more complex and time-consuming compared to the earlier system. 
 RC’s strengths and challenges related to operational conditions, and the actions planned for their 
development. 
Strengths.  The RC hosts strong multidisciplinary and broad arsenal of equipment and expertise.  The 
researchers are motivated, atmosphere is good and relaxed. Importantly, the research funding and 
infrastructure allow modern researcher education in this field.  
 
Challenges. The fragmented laboratory space is a problem.  The space situation will be investigated in 
2011. Hopefully, this results in improvements.  Protein engineering unit is needed in the RC. Such unit 
would enable engineering of large numbers of proteins as building blocks for nanostructures and other 
drug delivery systems.  This is highly important element in polymeric based bioconjugates. Small and 
medium scale devices are difficult to get funded, and maintenance of older instruments in working 
condition is difficult. 
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 Description of the execution and processes of leadership in the RC, how the management-related 
responsibilities and roles are distributed in the RC and how the leadership- and management-related 
processes support high quality research, collaboration between principal investigators and other 
researchers in the RC, the RC’s research focus and strengthening of the RC’s know-how.  
Centre for Drug Research (CDR) has a written strategy for the years 2010-2014. The strategy and results 
are evaluated by the International Advisory Board. This board will be used to evaluate the RC activity 
regularly in association of CDR evaluations. The leadership in the RC forms a steering group (Arto Urtti, 
Heikki Tenhu, Marjo Yliperttula).  CDR research manager will be the secretary in steering group meetings 
and takes care of many administrative duties in the RC.  The steering group decides the direction and 
strategy of the RC.  The decisions will be executed by the senior level scientists, who have 
responsibilities of different segments of the RC depending on the expertise field of each senior 
researcher. Senior scientists from various disciplines act in concert. Steering group and senior 
researchers will also have joint meetings and brainstorming workshops about the science in the field of 
the RC.  
 
The RC promotes the careers of the senior researchers so that they are encouraged to apply grants and 
to form research groups within the RC.  Tutoring is provided in grant proposal writing. This facilitates 
academic growth and maturation and makes the RC less vulnerable.  
 
We believe that these arrangements support high quality research. The RC has culture of critical 
scientific discussion.  
  
Collaboration between principal investigators and other researchers in the RC includes shared 
responsibilities, regular group meetings and seminars of groups.  
 
The RC's research focus is supported by grant applications, i.e. the grants are applied in the focus area of 
the RC. Infrastructure of RC available for all the researchers.  
 
Srengthening of the RC's know-how. Key personnel has been recruited during 2005-2010 in the fields 
that are needed for the RC research programme. Thus, experts have been hired in the fields of protein 
engineering, peptide and oliginucleotide synthesis, molecular modeling, surface chemistry, cell biology, 
in vivo imaging, cancer research, and controlled syntheses of polymers. 
 RC’s strengths and challenges related to leadership and management, and the actions planned for 
developing the processes. 
Strengths.  Researchers are trusted, atmosphere is good and easy going. The RC has healthy balance of 
personnel at various levels.  Regular development discussions.  
 
Challenges. The RC is fairly large and thus the increased involvement of senior level researchers is 
essential in the management of the RC.  Fund raising is a challenge, but larger involvement of senior 
researchers and the support of research manager should improve the logistics.  The RC is relatively new 
consortium, and it is still searching for the best ways of operation. 
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 Listing of the RCs external competitive funding, where: 
- the funding decisions have been made during 1.1.2005-31.12.2010, and 
- the administrator of the funding is/has been the University of Helsinki 
 
 Academy of Finland (AF) - total amount of funding (in euros) AF has decided to allocate to the RC 
members during 1.1.2005-31.12.2010: 3221 400 
 
 Finnish Funding Agency for Technology and Innovation (TEKES) - total amount of funding (in euros) 
TEKES has decided to allocate to the RC members during 1.1.2005-31.12.2010: 4430 000 
 
 European Union (EU) - total amount of funding (in euros) EU has decided to allocate to the RC members 
during 1.1.2005-31.12.2010: 2246 000 
 
 European Research Council (ERC) - total amount of funding (in euros) ERC has decided to allocate to the 
RC members during 1.1.2005-31.12.2010:  
 
 International and national foundations – names of international and national foundations which have 
decided to allocate funding to the RC members during 1.1.2005-31.12.2010, and the amount of their 
funding (in euros).  
- names of the foundations: Finnish Cultural Foundation, Eemil Aaltonen Foundation, Magnus 
Ehrnrooth Foundation, Alfred Kordelin Foundation, Fortum Foundation 
- total amount of funding (in euros) from the above-mentioned foundations: 110 000 
 
 Other international funding - names of other international funding organizations which have decided to 
allocate funding to the RC members during 1.1.2005-31.12.2010, and the amount of their funding (in 
euros). 
- names of the funding organizations: European Science Foundation, DAAD, Pharmaceutical and Life 
Science University of Tokyo, Santen Ltd, Spanish Government, Chinese Research Council, INTAS 
- total amount of funding (in euros) from the above-mentioned funding organizations: 527 600 
 
 Other national funding (incl. EVO funding and Ministry of Education and Culture funded doctoral 
programme positions) - names of other national funding organizations which have decided to allocate 
funding to the RC members during 1.1.2005-31.12.2010, and the amount of their funding (in euros). 
- names of the funding organizations: Chemical industries, University of Helsinki (CoE contribution), 
SalWe, Orion, Santen, BioNavis, Ark Therapeutics, Biocenter Finland 
- total amount of funding (in euros) from the above-mentioned funding organizations: 3218 000 
 
 
 
 Description of the RC’s future perspectives in respect to research and doctoral training. 
The CoE plan for generation of nanoparticle discovery pipeline is the core of the RC future action. The 
CoE plan requires concerted multidisciplinary effort to be successful.  The goal, nanoparticle discovery 
pipeline, thrives to generate systematic understanding to the field of nanoparticle drug delivery.  So far, 
very few nanoparticle products have reached the market despite decades of research.  This is due to the 
complexity of the delivery process and enormous number of possible nanoparticle formulations. This 
7 EXTERNAL COMPETITIVE FUNDING OF THE RC 
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plan integrates the bioinspired approaches, combinatorial assembly of nanoparticle libraries, automated 
cellular screening, mechanistic studies (physical, chemical, biological), and imaging studies to a 
systematic research platform. The targets of the project are retinal pigment epithelium and prostate 
cancer.  This kind of systematic, drug discovery like, research platform is needed to gain understanding 
of the complex process of drug delivery. The pipeline will most likely provide also new lead 
nanoparticles for further development.  
 
The plan involves the RC and two partners (Macromolecular Structure and Assembly group (Sarah 
Butcher, University of Helsinki) and High Throughput Biology group (Roland Grafström; VTT, Medical 
Biotechnology, Turku). Multidisciplinary international collaborating laboratories are integrated to the 
work packages. These groups are involved in synthesis of polymers and bioconjugates (Durham, 
Nijmegen, Montreal), measurements with expensive infrastructures (Karolinska, Trieste), and in vivo 
experiments with animal disease state models (Tübingen, Santa Barbara, Leiden).  
 
There will be also other research projects and activities in the RC in line with the research carried out in 
2005-2010, but building the nanoparticle discovery pipeline is expected to be the major effort. 
 
 
 
Comments on stage 2 material were collected from the entire personnel. Action plan (#8) was discussed 
among the senior level scientists during the Autumn 2010. 
9 SHORT DESCRIPTION OF HOW THE RC MEMBERS HAVE CONTRIBUTED TO THE COMPILATION OF THE STAGE 2 
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1 Analysis of publications 
 
- Associated person is one of Arto Urtti ,  Maxim Antopolsky ,  Marika Häkli ,  Päivi Tammela 
,  Lasse Murtomäki , Kim Bergström ,  Antti Petteri Laukkanen, Heidi Kidron , 
 Mari Raki ,  Sanjay Sarkhel ,  Margit Hornof, Julia Lehtinen ,  Astrid 
Elena Subrizi , Kati-Sisko Vellonen ,  Leena Kontturi ,  Mechthild Schmitt , 
 Johanna Linnankoski ,  Melina Malinen ,  Lauri Joonas Paasonen , 
Sreevani Kotha ,  Tatu Lajunen ,  Heikki Tenhu ,  Vladimir 
Aseyev ,  Sami Hietala ,  Anna Viktorovna Zarembo, Susanna Helmi Elisabet Holappa, Markus Nuopponen, Sami-
Pekka Hirvonen ,  Mikko Karesoja ,  Erno Johannes Karjalainen ,  Anu Alhoranta , 
 Jukka Niskanen ,  Petri Pulkkinen ,  Lauri Antero Valtola ,  
Szymon Jan Wiktorowicz ,  Marjo Yliperttula ,  Tapani Viitala ,  Hanna-Sisko 
Kortejärvi ,  Yan-Ru Lou ,  Paraskevi Kallinteri ,  Jonna Wikström , 
 Martina Hanzlikova ,  Niko Granqvist ,  Emilia Marie Claudia Galli , 
 Huamin Liang ,  Unni Kaarina Tengvall ,  Janne Marvola ,  
 
Publication year 
Publication type 2005 2006 2007 2008 2009 2010 
Total Count 2005 - 
2010 
A1 Refereed journal article 33 32 27 47 26 33 198 
A2 Review in scientific journal 1 1 1    3 
A3 Contribution to book/other compilations (refereed)   1 2 1 2 6 
A4 Article in conference publication (refereed)  2  2 2 2 8 
B1 Unrefereed journal article  1  1 2 1 5 
B2 Contribution to book/other compilations (non-refereed)     1  1 
B3 Unrefereed article in conference proceedings 1 1 1 1  1 5 
D3 Article in professional conference proceedings 1      1 
E1 Popular article, newspaper article    2   2 
H1 Patents     2 1 3 
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2 Listing of publications 
A1 Refereed journal article 
2005 
Aseyev, V, Hietala, S, Laukkanen, A, Nuopponen, M, Confortini, O, Du Prez, FE, Tenhu, H 2005, 'Mesoglobules of thermoresponsive 
polymers in dilute aqueous solutions above the LCST', Polymer, vol 46, no. 18, pp. 7118-7131. 
Burova, TV, Grinberg, NV, Grinberg, VY, Kalinina, EV, Lozinsky, VI, Aseyev, V, Holappa, S, Tenhu, H, Khokhlov, AR 2005, 'Unusual 
Conformational Behavior of Complexes of Poly(N-isopropylacrylamide) with Poly(methacrylic acid)',  Macromolecules, vol 38, no. 4, pp. 
1292-1299. 
Degni, S, Strandman, S, Laari, P, Nuopponen, M, Wilen, C, Tenhu, H, Rosling, A 2005, 'New soluble TADDOL-bearing polymers. 
Preparation and their use as Ti-complex catalysts for enantioselective addition of diethylzinc to benzaldehyde.', Reactive and 
Functional Polymers, vol 62, no. 3, pp. 231-240. 
Degni, S, Strandman, S, Laari, P, Nuopponen, M, Wilen, C, Tenhu, H, Rosling, A 2005, 'New solube TADDOL-bearing polymers. 
Preparation and their use as Ti-complex catalysts for enantioselective addition of diehylzinc to benzaldehyde',  Reactive and Functional 
Polymers, vol 62, no. 3, pp. 231-240. 
Dubruel, P, Urtti, A, Schacht, E 2005, 'Surface plasmon resonance Spectroscopy as a tool to study polyplex-glycoaminoglycan 
interactions', Macromolecular Rapid Communications, vol 26, pp. 992-997. 
Dudkina, M, Aseyev, V, Tenkovtsev, A, Tenhu, H  2005, 'Interaction and ionic network formation process between polyamidine and 
nonlinear optically active dyes.', Journal of Polymer Science. Part B, Polymer Physics, vol 43, no. 4, pp. 398-404. 
Galant, C, Kjøniksen, A, Knudsen, KD, Helgesen, G, Lund, R, Laukkanen, A, Tenhu, H, Nyström, B 2005, 'Physical properties of 
aqueous solutions of a thermo-responsive neutral copolymen and an anionic surfactant: Turbidity and small-angle neutron scattering 
studies', Langmuir, vol 21, no. 17, pp. 8010-8018. 
Galant, C, Kjoniksen, A, Knudsen, KD, Helgesen, G, Lund, R, Laukkanen, A, Tenhu, H, Nyström, B 2005, 'Physical Properties of 
Aqueous Solutions of a Thermo-Responsive Neutral Copolymer and an Anionic Surfactant: Turbidity and Small-Angle Neutron 
Scattering Studies.', Langmuir, vol 21, no. 17, pp. 8010-8018. 
Holappa, S, Kantonen, L, Andersson, T, Winnik, F, Tenhu, H 2005, 'Overcharging of Polyelectrolyte Complexes by the Guest 
Polyelectrolyte Studied by Fluorescence Spectroscopy.', Langmuir, vol 21, no. 24, pp. 11431-11438. 
Holappa, S, Kantonen, L, Andersson, T, Winnik, F, Tenhu, H 2005, 'Overcharging of polyelectrolyte complexes by the guest 
polyelectrolyte studied by fluorwscence spectroscopy',  Langmuir, vol 21, no. 24, pp. 11431-11438. 
Huhtinen, P, Kivelä, M, Kuronen, O, Hagren, V, Takalo, H, Tenhu, H, Lövgren, T, Härmä, H 2005, 'Synthesis, Characterization, and 
Application of Eu(III), Tb(III), Sm(III), and Dy(III) Lanthanide Chelate Nanoparticle Labels', Analytical Chemistry, vol 77, no. 8, pp. 
2645-2648. 
Häkli, M, Karvonen, U, Jänne, O, Palvimo, J 2005, 'SUMO-1 promotes association of SNURF (RNF4) with PML nuclear bodies', 
Experimental Cell Research, vol 304, pp. 224-233. 
Hänninen, K, Kaukonen, AM, Murtomäki, LS, Hirvonen, J 2005, 'Effect of ion-exchange fiber structure on the binding and release of 
model salicylates', Journal of Pharmaceutical Sciences, vol 94, no. 8, pp. 1772-1781. 
Kjoniksen, A, Laukkanen, A, Galant, C, Knudsen, KD, Tenhu, H, Nyström, B 2005, 'Association in Aqueous Solutions of a 
Thermoresponsive PVCL-g-C11EO42 Copolymer.', Macromolecules, vol 38, no. 3, pp. 948-960. 
Kreander, K, Vuorela, P, Tammela, P 2005, 'A Rapid screening method for detecting active compounds against erythromycin-resistant 
bacterial strains of finnish origin', Folia Microbiologica, vol 50, no. 6, pp. 487-493. 
Laukkanen, A, Valtola, L, Winnik, FM, Tenhu, H 2005, 'Thermosensitive graft copolymers of an amphiphilic macromonomer and N-
vinylcaprolactam: synthesis and solution properties in dilute aqueous solutions below and above the LCST',  Polymer, vol 46, no. 18, pp. 
7055-7065. 
Laukkanen, A, Winnik, FM, Tenhu, H 2005, 'Pyrene-labelled graft copolymers of N-Vinylcaprolactam : synthesis and solution properties 
in water', Macromolecules, vol 38, no. 6, pp. 2439-2448. 
Laukkanen, A, Winnik, FM, Tenhu, H 2005, 'Pyrene-labeled graft copolymers of N-vinylcaprolactam: synthesis and solution properties in 
water.', Macromolecules, vol 38, no. 6, pp. 2439-2448. 
Mannermaa, E, Ronkko, S, Ruponen, M, Reinisalo, M, Urtti, A 2005, 'Long-lasting secretion of transgene product from differentiated and 
filter-grown retinal pigment epithelial cells after nonviral gene transfer', Current Eye Research, vol 30, pp. 345-353. 
Mannermaa, E, Rönkkö, S, Urtti, A 2005, 'Non-invasive kinetic analysis of transgene expression in differentiated cultured retinal pigment 
epithelial cells', Current Eye Research, no. 30, pp. 345-353. 
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Mannisto, M, Ronkko, S, Matto, M, Honkakoski, P, Hyttinen, M, Pelkonen, J, Urtti, A 2005, 'The role of cell cycle on polyplex-mediated 
gene transfer into a retinal pigment epithelial cell line', Journal of Gene Medicine, vol 7, pp. 466-476. 
Männistö, M, Rönkkö, S, Ruponen, M, Pitkänen, L, Mättö, M, Pelkonen, J, Urtti, A 2005, 'Cell cycle effects on polyplex mediated gene 
transfer into retinal pigment epithelial cell line', Journal of Gene Medicine, vol 2005, no. 7, pp. 466-476. 
Pappinen, S, Pasonen-Seppanen, S, Suhonen, M, Tammi, R, Urtti, A 2005, 'Rat epidermal keratinocyte organotypic culture (ROC) as a 
model for chemically induced skin irritation testing', Toxicology and Applied Pharmacology, vol 208, pp. 233-241. 
Pitkanen, L, Ranta, VP, Moilanen, H, Urtti, A 2005, 'Permeability of retinal pigment epithelium: Effects of permeant molecular weight and 
lipophilicity', Investigative Ophthalmology & Visual Science, vol 46, pp. 641-646. 
Raki, M, Kanerva, A, Ristimäki, A, Desmond, RA, Chen, D, Ranki, T, Särkioja, M, Kangasniemi, L, Hemminki, A 2005, 'Combination of 
gemcitabine and Ad5/3-Delta24, a tropism modified conditionally replicating adenovirus, for the treatment of ovarian cancer', Gene 
Therapy (Basingstoke), vol 12, no. 15, pp. 1198-1205. 
Ruponen, M, Hyvönen, Z, Urtti, A, Ylä-Herttuala, S 2005, 'Nonviral gene deliver methods in cardiovascular diseases',  Methods in 
Molecular Medicine, vol 108, pp. 318-328. 
Shan, J, Nuopponen, M, Jiang, H, Viitala, T, Kauppinen, E, Kontturi, K, Tenhu, H 2005, 'Amphiphilic gold nanoparticles grafted with 
poly(N-isopropylacrylamide) and polystyrene', Macromolecules, vol 38, no. 7, pp. 2918-2926. 
Strandman, S, Pulkkinen, P, Tenhu, H 2005, 'Effect of ligand on the synthesis of star polymers by resorcinarene-based ATRP initiators', 
Journal of Polymer Science. Part A, Polymer Chemistry, vol 43, no. 15, pp. 3349-3358. 
Tammela, P, Salo-Väänänen, P, Laakso, I, Hopia, A, Vuorela, H, Nygren, M 2005, 'Tocopherols, tocotrienols and fatty acids as 
indicators of natural ageing in Pinus sylvestris seeds', Scandinavian Journal of Forest Research, vol 20, no. 5, pp. 378-384. 
Tammela, P 2005, 'Seulontamenetelmien kehittäminen biologisen aktiivisuuden evaluointiin lääketutkimuksessa', Dosis, vol 21, no. 4, 
pp. 319-326. 
Vihola, H, Laukkanen, A, Valtola, L, Tenhu, H, Hirvonen, J 2005, 'Cytotoxicity of thermosensitive polymers poly(N-isopropylacrylamide), 
poly(N-vinylcaprolactam) and amphiphilically modified poly(N-vinylcaprolactam)', Biomaterials, vol 26, no. 16, pp. 3055-3064. 
Yohannes, G, Holappa, S, Wiedmer, SK, Andersson, T, Tenhu, H, Riekkola, M 2005, 'Polyelectrolyte complexes of 
poly(methacryloxyethyl trimethylammonium chloride) and poly(ethylene oxide)-block-poly(sodium methacrylate) studied by asymmetrical 
flow field-flow fractionation and dynamic light scattering', Analytica Chimica Acta, vol 542, no. 2, pp. 222-229. 
Yohannes, G, Shan, J, Jussila, M, Nuopponen, M, Tenhu, H, Riekkola, M 2005, 'Characterisation of poly(N-isopropylacrylamide) by 
asymmetrical flow field-flow fractionation, dynamic light scattering, and size exclusion chromatography.', Journal of Separation 
Science, vol 28, no. 5, pp. 435-442. 
2006 
Alvesalo, J, Vuorela, H, Tammela, P, Leinonen, M, Saikku, P, Vuorela, P  2006, 'Inhibitory effect of dietary phenolic compounds on 
Chlamydia pneumoniae in cell cultures', Biochemical Pharmacology, vol 71, no. 6, pp. 735-741. 
Alvesalo, J, Siiskonen, A, Vainio, M, Tammela, P, Vuorela, P 2006, 'Similarity based virtual screening: a tool for targeted library design', 
Journal of Medicinal Chemistry, vol 49, no. 7, pp. 2353-2356 . 
Andersson, T, Holappa, S, Aseyev, V, Tenhu, H 2006, 'Effect of Polycation Length on Its Complexation with DNA and with 
Poly(oxyethylene-block-sodium methacrylate).',  Biomacromolecules, vol 7, no. 11, pp. 3229-3238. 
Andersson, M, Hietala, S, Tenhu, H, Maunu, S 2006, 'Polystyrene latex particles coated with crosslinked poly(N-isopropylacrylamide)',  
Colloid and Polymer Science, vol 284, pp. 1255-1263. 
Anghelescu-Dogaru, AG, Chitanu, GC, Tenhu, H 2006, 'Interaction of maleic acid copolymers with collagen: 1. homogeneous and 
phase separating systems', Macromolecular Symposia, vol 239, pp. 68-76. 
Anghelescu-Dogaru, AG, Chitanu, GC, Tenhu, H 2006, 'Interaction of maleic acid copolymers with collagen 1. Homogeneous and phase 
separating systems.', Macromolecular Symposia, vol 239, no. 1/Special Issue: Advanced Polymers, Composites and Technologies, 
pp. 68-76. 
Aseyev, V, Tenhu, H, Winnik, FM 2006, 'Temperature dependence of the colloidal stability of neutral amphiphilic polymers in water.', 
Advances in Polymer Science, vol 196, no. Conformation-Dependent Design of Sequences in Copolymers II, pp. 1-85. 
Darinskii, AA, Zarembo, A, Balabaev, NK, Neelov, IM, Sundholm, F 2006, 'Molecular dynamic simulation of side-chain liquid crystalline 
elastomer', Macromolecular Symposia, vol 237, pp. 119-127. 
Fallarero, A, Peltoketo, A, Loikkanen, J, Tammela, P, Vidal, A, Vuorela, P  2006, 'Effects of the aqueous extract of Bryothamnion 
triquetrum on chemical hypoxia and aglycemia-induced damage in GTI-7 mouse hypothalamic immortalized cells', Phytomedicine, vol 
13, no. 4, pp. 240-245. 
Hietala, S, Nyström, A, Tenhu, H, Hult, A 2006, 'Solution properties of dendronized poly(hydroxy ethyl methacrylate) polymers',  Journal 
of Polymer Science. Part A, Polymer Chemistry, vol 44, pp. 3674-3683. 
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models of disseminated gastric cancer',  Clinical Cancer Research, vol 12, no. 10, pp. 3137-3144. 
Kortejärvi, H, Malkki, J, Marvola, M, Urtti, A, Yliperttula, M, Pajunen, P 2006, 'Level A in vitro-in vivo correlation (IVIVC) model with 
Bayesian approach to formulation series',  Journal of Pharmaceutical Sciences, vol 95, pp. 1595-1605. 
Kostiainen, MA, Szilvay, GR, Lehtinen, J, Smith, DK, Linder, MB, Urtti, A, Ikkala, O 2006, 'Precisely defined protein-polymer conjugates: 
construction of synthetic DNA binding domains on proteins by using multivalent dendrons',  ACS nano., vol 1, no. 2, pp. 103-113. 
Kreander, K, Galkin, A, Vuorela, S, Tammela, P, Laitinen, L, Heinonen, M, Vuorela, P 2006, 'In-vitro mutagenic potential and effect on 
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and Pharmacology, vol 58, no. 11, pp. 1545-1552. 
Kreander, K, Kurkela, M, Siiskonen, A, Vuorela, P, Tammela, P 2006, 'Identification of COMT and ErmC inhibitors by using a microplate 
assay in combination with library focusing by virtual screening', Pharmazie, vol 61, no. 3, pp. 247-248. 
Kujawa, P, Aseyev, V, Tenhu, H, Winnik, FM 2006, 'Temperature-sensitive properties of poly(N-isopropylacrylamide) mesoglobules 
formed in dilute aqueous solutions heated above their demixing point', Macromolecules, vol 39, pp. 7686-7693. 
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characterization of dielectric elastomer EAP materials.', VTT symposium, vol 244, pp. 50-60. 
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paracetamol', European Journal of Pharmaceutics and Biopharmaceutics, vol 71, pp. 55-63. 
Huhtala, A, Rönkkö, S, Teräsvirta, M, Puustjärvi, T, Sihvola, R, Vehanen, K, Laukkanen, A, Anttila, J, Urtti, A, Pohjonen, T, Uusitalo, H 
2009, 'Effects of 5-fluorouracil on ocular tissues in vitro and in vivo after controlled release from a multifunctional implant',  Investigative 
Ophthalmology & Visual Science, vol 50, no. 5, pp. 2216-2222. 
Karesoja, M, Jokinen, H, Karjalainen, E, Pulkkinen, P, Torkkeli, M, Soininen, A, Ruokolainen, J, Tenhu, H 2009, 'Grafting of 
montmorillonite nano-clay with butyl acrylate and methyl methacrylate by atom transfer radical polymerization: Blends with poly(BuA-co-
MMA)', Journal of Polymer Science. Part A, Polymer Chemistry, vol 47, no. 12, pp. 3086-3097. 
Laaksonen, TJ, Laaksonen, HM, Hirvonen, JT, Murtomaki, L 2009, 'Cellular automata model for drug release from binary matrix and 
reservoir polymeric devices', Biomaterials, vol 30, pp. 1978-1987. 
Lintinen, K, Storbacka, L, Efimov, A, Hietala, S, Ahorinta, R, Tkachenko, N, Lemmetyinen, H 2009, 'Monitoring ultrathin film 
photopolymerization of tetra-alkylepoxyporphyrin by UV-Vis spectroscopy', Journal of Polymer Science. Part A, Polymer Chemistry, 
vol 47, pp. 6095-6103. 
Mannermaa, E, Vellonen, K, Ryhänen, T, Kokkonen, K, Ranta, V, Kaarniranta, K, Urtti, A 2009, 'Efflux protein expression in human 
retinal pigment epithelium cell lines', Pharmaceutical Research, vol 26, no. 7, pp. 1785-1791. 
Munk, T, Hietala, S, Kalliomäki, K, Nuopponen, M, Tenhu, H, Tian, F, Rantanen, J, Baldursdottir, S 2009, 'Rheological behaviuor of 
poly(N-isopropyl acrylamide) in water-acetone mixtures.', Annual Transactions of the Nordic Rheology Society, vol 17, pp. 113-118. 
Pauwels, E, Bergström, K, Mariani, G, Kairemo, K 2009, 'Microdosing, Imaging Biomarkers and SPECT: A Multi-Sided Tripod to 
Accelerate Drug Development', Current Pharmaceutical Design, vol 15, no. 9, pp. 928-934. 
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Plamper, FA, McKee, JR, Laukkanen, A, Nykänen, A, Walther, A, Ruokolainen, J, Aseyev, V, Tenhu, H 2009, 'Miktoarm stars of 
poly(ethylene oxide) and poly(dimethylaminoethyl methacrylate): manipulation of micellization by temperature and light', Soft Matter, vol 
5, no. 9, pp. 1812-1821. 
Plamper, FA, Murtomäki, L, Walther, A, Kontturi, K, Tenhu, H 2009, 'e-Micellization: Electrochemical, reversible switching of polymer 
aggregation', Macromolecules, vol 42, no. 19, pp. 7254-7257. 
Pohjala, L, Alakurtti, S, Ahola, T, Yli-Kauhaluoma, J, Tammela, P 2009, 'Betulin-derived compounds as inhibitors of alphavirus 
replication', Journal of Natural Products, vol 72, no. 11, pp. 1917-1926. 
Pulkkinen, P, Shan, J, Leppänen, K, Känsäkoski, A, Järn, M, Tenhu, H, Laiho, A 2009, 'Poly(ethylene imine) and 
Tetraethylenepentamine as Protecting Agents for Metallic Copper Nanoparticles', ACS Applied Materials & Interfaces, vol 1, no. 2, pp. 
519-525. 
Rezende, CA, Shan, J, Lee, L, Zalczer, G, Tenhu, H 2009, 'Tuning the structure of thermosensitive gold nanoparticle monolayers',  
Journal of Physical Chemistry B, vol 113, no. 29, pp. 9786-9794. 
Ruponen, M, Arkko, S, Urtti, A, Reinisalo, M, Ranta, V 2009, 'Intracellular DNA release and elimination correlate poorly with transgene 
expression after non-viral transfection', Journal of Controlled Release, vol ,136, no. 3, pp. 226-231. 
Shan, J, Zhao, Y, Granqvist, N, Tenhu, H 2009, 'Thermoresponsive properties of N-isopropylacrylamide oligomer brushes grafted to 
gold nanoparticles: Effects of molar mass and gold core size', Macromolecules, vol 42, no. 7, pp. 2696-2701. 
Subrizi, A, Yliperttula, M, Tibaldi, L, Schacht, E, Dubruel, P, Joliot, A, Urtti, A 2009, 'Optimized transfection protocol for efficient in vitro 
non-viral polymeric gene delivery to human retinal pigment epithelial cells (ARPE-19)', Nature Protocols. 
Valtola, L, Koponen, A, Karesoja, M, Hietala, S, Laukkanen, A, Tenhu, H, Denifl, P  2009, 'Tailored surface properties of semi-fluorinated 
block copolymers by electrospinning.', Polymer, vol 50, no. 14, pp. 3103-3110. 
Valtola, L, Hietala, S, Tenhu, H, Denifl, P, Wilen, C 2009, 'Association behavior and properties of copolymers of perfluorooctyl ethyl 
methacrylate and eicosanyl methacrylate', Polymers for Advanced Technologies, vol 2009, no. 20, pp. 225-234. 
Xie, H, Järvi, P, Karesoja, M, King, A, Kilpeläinen, I, Argyropoulos, DS 2009, 'Highly compatible wood thermoplastic composites from 
lignocellulosic material modified in ionic liquids: preparation and thermal properties', Journal of Applied Polymer Science, vol 111, pp. 
2468-2476. 
Zhao, J, Shan, J, Van Assche, G, Tenhu, H, Van Mele, B 2009, 'Demixing and remixing kinetics in aqueous dispersions of poly(N-
isopropylacrylamide) (PNIPAM) brushes bound to gold nanoparticles studied by means of modulated temperature differential scanning 
calorimetry', Macromolecules, vol 42, no. 14, pp. 5317-5327. 
2010 
Bogdan, A, Molina, MJ, Tenhu, H, Mayer, E, Loerting, T 2010, 'Formation of mixed-phase particles during the freezing of polar 
stratospheric ice clouds.', Nature Chemistry, vol 2, no. 3, pp. 197-201. 
Bogdan, A, Molina, MJ, Tenhu, H, Mayer, E, Loerting, T 2010, 'Different freezing behavior of millimeter- and micrometer-scaled 
(NH4)2SO/H2O droplets', Journal of Physics: Condensed Matter, vol 23, no. 3, pp. 1-6. 
Cerullo, V, Pesonen, S, Diaconu, I, Escutenaire, S, Arstila, PT, Ugolini, M, Nokisalmi, P, Raki, M, Laasonen, L, Sarkioja, M, Rajecki, M, 
Kangasniemi, L, Guse, K, Helminen, A, Ahtiainen, L, Ristimäki, A, Räisänen-Sokolowski, A, Haavisto, E, Oksanen, M, Karli, E, Karioja-
Kallio, A, Holm, S, Kouri, M, Joensuu, T, Kanerva, A, Hemminki, A 2010, 'Oncolytic Adenovirus Coding for Granulocyte Macrophage 
Colony-Stimulating Factor Induces Antitumoral Immunity in Cancer Patients', Cancer Research, vol 70, no. 11, pp. 4297-4309. 
Greco, D, Vellonen, K, Turner, HC, Häkli, M, Tervo, T, Auvinen, P, Wolosin, JM, Urtti, A 2010, 'Gene expression analysis in SV-40 
immortalized human corneal epithelial cells cultured with an air-liquid interface', Molecular Vision, vol 16, pp. 2109-2120. 
Ikonen, M, Murtomäki, L, Kyösti, K 2010, 'Microcalorimetric and zeta potential study on binding of drugs on liposomes', Colloids and 
Surfaces B: Biointerfaces, vol 78, no. 2, pp. 275-282. 
Kartal, A, Marvola, J, Matheka, J, Peltoniemi, M, Siven, M 2010, 'Computational prediction of local drug effect on carcinogenic 
acetaldehyde in the mouth based on in vitro/in vivo results of freely soluble L-cysteine',  Drug Development and Industrial Pharmacy, 
vol 36, no. 6, pp. 715-723. 
Kidron, H, Vellonen, K, Del Amo Paez, E, Tissari, A, Urtti, A 2010, 'Prediction of the Corneal Permeability of Drug-Like Compounds', 
Pharmaceutical Research, vol 27, no. 7, pp. 1398-1407. 
Kivelä, R, Pitkänen, LM, Laine, P, Aseyev, V, Sontag-Strohm, T  2010, 'Influence of homogenisation on the solution properties of oat -
glucan', Food Hydrocolloids, vol 24, no. 6-7, pp. 611-618. 
Koivula, T, Laine, J, Lipponen, T, Perhola, O, Kämäräinen, E, Bergström, K, Solin, O 2010, 'Assessment of labelled products with 
different radioanalytical methods: study on 18F-fluorination reaction of 4-[18F]fluoro-N-[2-[1-(2-methoxyphenyl)-1-piperazinyl]ethyl-N-2-
pyridinyl-benzamide (p-[18F]MPPF)', Journal of Radioanalytical and Nuclear Chemistry, vol 286, no. 3, pp. 841. 
 
 
DePoNa/Urtti 
 
 
10 
 
INTERNATIONAL EVALUATION OF RESEARCH AND DOCTORAL TRAINING AT THE 
UNIVERSITY OF HELSINKI  
 
RC-SPECIFIC TUHAT COMPILATIONS OF PUBLICATIONS DATA 2005-2010 
 
 
Kortejärvi, H, Shawahna, R, Koski, A, Malkki, J, K., O, Yliperttula, M 2010, 'Very rapid dissolution is not needed to guarantee 
bioequivalence for biopharmaceutics classification system (BCS) I drugs',  Journal of Pharmaceutical Sciences, vol 99, no. 2, pp. 621-
5. 
Koski, A, Kangasniemi, L, Escutenaire, S, Pesonen, S, Cerullo, V, Diaconu, I, Nokisalmi, P, Raki, M, Rajecki, M, Guse, K, Ranki, T, 
Oksanen, MK, Holm, S, Haavisto, E, Karioja-Kallio, A, Laasonen, L, Partanen, K, Ugolini, M, Helminen, A, Karli, E, Hannuksela, P, 
Pesonen, S, Joensuu, T, Kanerva, A, Hemminki, A 2010, 'Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic 
Adenovirus Expressing GMCSF', Molecular therapy, vol 18, no. 10, pp. 1874-1884. 
Kozlov, AS, Petrov, AK, Kulipanov, GN, Aseyev, V 2010, 'A Novel Method of Probing the Fractional Composition of Nanosystems', 
KONA: Powder and Particle Journal, vol 28, pp. 219-226. 
Kulovesi, P, Telenius, J, Koivuniemi, A, Brezesinski, G, Rantamäki, A, Viitala, T, Puukilainen, E, Ritala, M, Wiedmer, SK, Vattulainen, 
IT, Holopainen, JM 2010, 'Molecular Organization of the Tear Fluid Lipid Layer', Biophysical Journal, vol 99, no. 8, pp. 2559-2567. 
Liang, H, Miranto, H, Granqvist, N, Sadowski, JW, Viitala, T, Wang, B, Yliperttula, M 2010, 'Surface plasmon resonance instrument as a 
refractometer for liquids and ultrathin films', Sensors and Actuators B: Chemical, vol 149, no. 1, pp. 212-220. 
Linnankoski, J, Makela, J, Palmgren, J, Mauriala, T, Vedin, C, Ungell, A, Lazorova, L, Artursson, P, Urtti, A, Yliperttula, M  2010, 
'Paracellular Porosity and Pore Size of the Human Intestinal Epithelium in Tissue and Cell Culture Models',  Journal of Pharmaceutical 
Sciences, vol 99, pp. 2166-2175. 
Lou, Y, Molnar, F, Perakyla, M, Qiao, S, Kalueff, AV, St-Arnaud, R, Carlberg, C, Tuohimaa, P 2010, '25-Hydroxyvitamin D-3 is an 
agonistic vitamin D receptor ligand', Journal of Steroid Biochemistry and Molecular Biology, vol 118, no. 3, pp. 162-170. 
Mannermaa, E, Reinisalo, M, Ranta, V, Vellonen, K, Kokki, H, Saarikko, A, Kaarniranta, K, Urtti, A 2010, 'Filter-cultured ARPE-19 cells 
as outer blood-retinal barrier model', European Journal of Pharmaceutical Sciences, vol 40, pp. 289-296. 
Niskanen, J, Shan, J, Tenhu, H, Jiang, H, Kauppinen, E, Barranco, V, Pico, F, Yliniemi, K, Kontturi, K 2010, 'Synthesis of copolymer-
stabilized silver nanoparticles for coating materials',  Colloid and Polymer Science, vol 288, no. 5, pp. 543-553. 
Nokisalmi, P, Pesonen, S, Escutenaire, S, Sarkioja, M, Raki, M, Cerullo, V, Laasonen, L, Alemany, R, Rojas, J, Cascallo, M, Guse, K, 
Rajecki, M, Kangasniemi, L, Haavisto, E, Karioja-Kallio, A, Hannuksela, P, Oksanen, MK, Kanerva, A, Joensuu, T, Ahtiainen, L, 
Hemminki, A 2010, 'Oncolytic Adenovirus ICOVIR-7 in Patients with Advanced and Refractory Solid Tumors',  Clinical Cancer 
Research, vol 16, pp. 3035-3043. 
Paasonen, LJ, Sipilä, T, Subrizi, AE, Laurinmäki, PA, Butcher, S, Rappolt, M, Yaghmur, A, Urtti, A, Yliperttula, M 2010, 'Gold-embedded 
photosensitive liposomes for drug delivery: triggering mechanism and intracellular release.', Journal of Controlled Release, vol 147, 
no. 1, pp. 136-143. 
Pesonen, S, Nokisalmi, P, Escutenaire, S, Sarkioja, M, Raki, M, Cerullo, V, Kangasniemi, L, Laasonen, L, Ribacka, C, Guse, K, 
Haavisto, E, Oksanen, MK, Rajecki, M, Helminen, A, Ristimaki, A, Karioja-Kallio, A, Karli, E, Kantola, T, Bauerschmitz, G, Kanerva, A, 
Joensuu, T, Hemminki, A 2010, 'Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with 
metastatic and refractory solid tumors', Gene Therapy (Basingstoke), vol 17, no. 7, pp. 892-904. 
Pirkonen, P, Setälä, H, Kyllönen, H, Sarlin, J, Salo, K, Tenhu, H, Ruuskanen, P 2010, 'Thermal stimuli controlled functional filter cloth for 
liquid filtration', Filtration (Coalville), vol 10, no. 2, pp. 144-152. 
Plamper, FA, Reinicke, S, Elomaa, M, Schmalz, H, Tenhu, H 2010, 'Pearl Necklace Architecture: New Threaded Star-Shaped 
Copolymers.', Macromolecules, vol 43, no. 5, pp. 2190-2203. 
Ranta, V, Mannermaa, E, Lummepuro, K, Subrizi, AE, Laukkanen, AP, Antopolsky, M, Murtomäki, L, Hornof, M, Urtti, A 2010, 'Barrier 
analysis of periocular drug delivery to the posterior segment',  Journal of Controlled Release, vol 148, no. 1, pp. 42-48. 
Ruokolainen, J, Nykänen, A, Priimägi, A, Rahikkala, A, Hirvonen, S, Raula, J, Tenhu, H, Kauppinen, E, Mezzenga, R 2010, 
'Temperature controlled release from polystyrene-block-poly(N-isopropylacrylamide-block-polystyrene block copolymer hydrogel.',  
Journal of Controlled Release, vol 148, no. 1, pp. e53-e54. 
Soikkeli, A, Sempio, C, Kaukonen, AM, Urtti, A, Hirvonen, J, Yliperttula, M 2010, 'Feasibility Evaluation of 3 Automated Cellular Drug 
Screening Assays on a Robotic Workstation', Journal of Biomolecular Screening, vol 15, pp. 30-41. 
Tenkovtsev, AV, Dudkina, MM, Scherbinskaya, LI, Aseyev, V, Tenhu, H 2010, 'Star-shaped macromolecules with calixarene core and 
neutral amphiphilic block copolymer arms: New hosts for ions.',  Polymer, vol 51, no. 14, pp. 3108-3115. 
Vellonen, K, Mannermaa, E, Turner, H, Häkli, M, Wolosin, JM, Tervo, TMT, Honkakoski, P, Urtti, A  2010, 'Effluxing ABC transporters in 
human corneal epithelium.', Journal of Pharmaceutical Sciences, vol 99, no. 2, pp. 1087-1098. 
Vellonen, K, Hakli, M, Merezhinskaya, N, Tervo, T, Honkakoski, P, Urtti, A 2010, 'Monocarboxylate transport in human corneal 
epithelium and cell lines', European Journal of Pharmaceutical Sciences, vol 39, pp. 241-247. 
Viiri, J, Hyttinen, J, Ryhänen, T, Rilla, K, Palmela, T, Kuusisto, E, Siitonen, A, Salminen, A, Urtti, A, Kaarniranta, K 2010, 
'p62/sequestome 1 as a regulator of a proteasome inhibitor-induced autophagy in human retinal pigment epithelial cells',  Molecular 
Vision, vol 16, pp. 1399-1414. 
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Wang, Z, Reinach, PS, Zhang, F, Vellonen, K, Urtti, A, Turner, H, Wolosin, JM  2010, 'DUSP5 and DUSP6 modulate corneal epithelial 
cell proliferation', Molecular Vision, vol 16, no. 183-84, pp. 1696-1704. 
Yaghmur, A, Paasonen, L, Yliperttula, M, Urtti, A, Rappolt, M 2010, 'Structural Elucidation of Light Activated Vesicles', Journal of 
Physical Chemistry Letters, vol 1, pp. 962-966. 
Yohannes, G, Wiedmer, SK, Elomaa, M, Jussila, M, Aseyev, V, Riekkola, M 2010, 'Thermal aggregation of bovine serum albumin 
studied by asymmetrical flow field-flow fractionation', Analytica Chimica Acta, vol 675, no. 2, pp. 191-198. 
A2 Review in scientific journal 
2005 
Hornof, M, Toropainen, E, Urtti, A 2005, 'Cell culture models of the ocular barriers', European Journal of Pharmaceutics and 
Biopharmaceutics, vol 60, pp. 207-225. 
2006 
Raki, M, Rein, DT, Kanerva, A, Hemminki, A 2006, 'Gene transfer approaches for gynecological diseases', Molecular therapy, vol 14, 
no. 2, pp. 154-163. 
2007 
Kanerva, A, Raki, M, Hemminki, A 2007, 'Gene therapy of gynaecological diseases: [review]',  Expert Opinion on Biological Therapy, 
vol 7, no. 9, pp. 1347-1361. 
A3 Contribution to book/other compilations (refereed) 
2007 
Laukkanen, A, Tenhu, H 2007, 'Thermally responsive polymers with amphiphilic grafts: smart polymers by macromonomer technique', 
Smart polymers, CRC Press, Boca Raton, FL, pp. 115-135. 
2008 
Laukkanen, A, Tenhu, H 2008, 'Thermally responsive polymers with amphiphilic grafts: smart polymers by macromonomer technique', in 
I Galaev, B Mattiasson (eds), Smart Polymers. Applications in Biotechnology and Biomedicine., 2nd edn, CRC Press, pp. 115-
136. 
Raki, MP, Rajecki, MK, Kirn, D, Hemminki, AE 2008, 'Oncolytic viruses for treatment of cancer', in N Templeton (ed.), Cell and Gene 
Therapy . Therapeutic Mechanisms and Strategies., 3 edn, Marcel Dekker, New York. 
2009 
Urtti, A 2009, 'Ophthalmic Delivery of Protein and Peptide Therapeutics', in A Dougherty, R Mrsny (eds) , Pharmacokinetic, 
Pharmacodynamic and Metabolic Aspects of Therapeutic Proteins and Peptides, Informa healthcare . 
2010 
Aseyev, V, Tenhu, H, Winnik, F 2010, 'Non-ionic Thermoresponsive Polymers in Water', Self Organized Nanostrcutures of 
Amphiphilic Block Copolymers, Advances in Polymer Science , Springer Berlin Heidelberg, pp. 1-61. 
Urtti, A 2010, 'Ocular drug delivery systems: transscleral drug delivery to the posterior eye segment',  Biodrug Delivery Systems, 
Informa healthcare, New York, pp. 187-193. 
A4 Article in conference publication (refereed) 
2006 
Lehtinen, J, Subrizi, A, Bunjes, H, Urtti, A 2006, Anionic lipid coating protects cationic DNA-polymer complexes from 
glycosaminoglycans,, European Journal of Pharmaceutical Sciences 28 ELSEVIER BV. 
Tenhu, H 2006, Self-assembling of aqueous polyelectrolytes: Polyelectrolyte complex particles and micellar structures,. 
2008 
Hanzlikova, M, Galli, E, Urtti, A, Raasmaja, A, Ruponen, M, Yliperttula, M 2008, The role of free polyethylene imine (PEI) in gene 
delivery by DNA-PEI complexes,, Human Gene Therapy 19 MARY ANN/LIEBERT, INC. PUBLISHERS. 
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Subrizi, A, Antopolsky, M, Urtti, A 2008, Design and in vitro characterization of Tat derived cell-penetrating peptides,, Human Gene 
Therapy 19 MARY ANN/LIEBERT, INC. PUBLISHERS. 
2009 
Alakurtti, SA, Sacerdoti-Sierra, N, Pohjala, L, Jaffe, CL, Tammela, P, Yli-Kauhaluoma, J 2009, 'Pharmaceutical Applications of Birch 
Bark Extractive Betulin', in Science and technology of biomasses: advances and challenges (from forest and agricultural 
biomasses to high added value products, processes and materials), pp. 165-168. 
Cerullo, V, Pesonen, S, Diaconu, I, Escutenaire, S, Arstila, P, Ugolini, M, Nokisalmi, P, Raki, M, Laasonen, L, Rajecki, M, Kangasniemi, 
L, Guse, K, Joensuu, T, Kanerva, A, Hemminki, A 2009, Ad5-D24-GMCSF, an oncolytic adenovirus coding for GMCSF, induces anti-
tumoral immunity in human cancer patients,, Human Gene Therapy 20 MARY ANN/LIEBERT, INC. PUBLISHERS. 
2010 
Hanzlíková, M, Raula, J, Hautala, J, Kauppinen, E, Urtti, A, Yliperttula, M 2010, Preparation of solid DNA nanoparticles for use in gene 
therapy,, Drug Discovery Today 15 23-24 ELSEVIER. 
Mirza, S, Miroshnyk, I, Mohammadi , G, Alakurtti, SA, Hussain , M, Yli-Kauhaluoma, J, Urtti, A 2010, Electrospinning platform for 
fabrication of monodispersed nanoparticles for pharmaceutical applications,, Paper presented at 2010 FIP Pharmaceutical Sciences 
World Congress, New Orleans, United States. 14. - 18. November, 2010. AAPS Journal 12 S2 SPRINGER NEW YORK LLC. 
B1 Unrefereed journal article 
2006 
Urtti, A 2006, 'Ocular drug delivery', Advanced Drug Delivery Reviews. 
2008 
Kairemo, K, Bergström, K 2008, 'The role of radiopharmaceuticals in drug discovery', Current Radiopharmaceuticals, vol 1, no. 1, pp. 
1. 
2009 
Subrizi, AE, Yliperttula, M, Tibaldi, L, Schacht, E, Dubruel, P, Joliot, A, Urtti, A 2009, 'Optimized transfection protocol for efficient in vitro 
non-viral polymeric gene delivery to human retinal pigment epithelial cells (ARPE-19)', Protocol Exchange, no. 78. 
Tenhu, H 2009, 'In Memoriam', Muovi : Muoviyhdistys ry:n jäsenlehti., vol 5, pp. 31. 
2010 
Tuohimaa, P, Kuuslahti, M, Lou, Y 2010, 'Vitamin D3: Is there an upper limit?',  BMJ : British Medical Journal. 
B2 Contribution to book/other compilations (non-refereed) 
2009 
Tuohimaa, P, Lou, Y 2009, 'New Aspects of Vitamin D Endocrinology', in SR Malone (ed.), VITAMIN D: NUTRITION, SIDE EFFECTS 
AND SYMPTOMS , Nova Science Publishers, Hauppauge, NY, USA , pp. 119-131. 
B3 Unrefereed article in conference proceedings 
2005 
Hiltunen, M, Maunu, SL, Tenhu, H 2005, 'Synthesis and characterizations of new cellulose derivatives with controlled chemical structure 
of grafts by using RAFT polymerization', in 59th Appita Annual Conference, pp. 143-146 Appita Annual Conference , vol. 3. 
2006 
Muhonen, J, Lipponen, T, Bergström, K 2006, Ion trap mass spectrometry in the qualitative analysis of [18F] MPPF,, European Journal 
of Nuclear Medicine and Molecular Imaging 33 SPRINGER. 
2007 
Hiltunen, M, Maunu, SL, Tenhu, H 2007, 'New cellulose copolymers with controlled chemical structure of grafts via RAFT 
polymerization', in 14th International Symposium for Wood, Fibre &amp; Pulping Chemistry . 
2008 
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Järvi, PK, Olszewska, A, King, AWT, Granström, M, Hietala, SHO, Kilpeläinen, I, Argyropoulos, D  2008, 'Study of Rheological Behaviour 
of Microcrystalline Cellulose Dissolved in Two Different Ionic Liquids', in  10th European Workshop on Lignocellulosics and Pulp 
(Proceedings), pp. 177-180. 
2010 
Kivelä, R, Hietala, S, Sontag-Strohm, T, Turner, B, Bansil, R 2010, 'Oat -glucan affects the viscoelastic properties of gastric mucin at 
pH conditions of intestine.', in The 2nd Conference of Gluten Free products and Beverages, pp. 63-64. 
D3 Article in professional conference proceedings 
2005 
Säkkinen, M, Marvola, J, Marvola, M 2005, 'Are chitosan granules mucoadhesive in the human stomach - a gamma scintigraphic study 
in man.', in Proceedings of the 1st BBBB Conference on Pharmaceutical Sciences, pp. 224. 
E1 Popular article, newspaper article 
2008 
Sundholm, F, Tenhu, H 2008, 'J. Johan Lindberg polymeerikemian uuttera uranuurtaja: in memoriam', Kemia - Kemi, vol 35, no. 5, pp. 
81. 
Törmälä, P, Tenhu, H 2008, 'J. Johan Lindberg *18.9.1921 +28.6.2008: in memoriam',  Suomalainen Tiedeakatemia. Vuosikirja, pp. 
107-110. 
H1 Patents 
2009 
Maijala, J, Merta, J, Shan, J, Tenhu, H 2009, Novel particles and method of producing the same.,. 
Shan, J, Pulkkinen, P, Merta, J, Känsäkoski, A, Tenhu, H Sep. 24 2009, Novel materials based on nanoparticles having a metallic core 
and a protective amine wrapping., WO2009115643 (A2). 
2010 
Yli-Kauhaluoma, J, Koskimies, S, Alakurtti, SA, Bergström, P, Mäkelä, T, Vuorela, P, Tammela, P, Minkkinen, J, Pohjala, L Nov. 30 
2010, Betuliiniperäiset yhdisteet antimikrobisina aineina, 121468. 
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1 Analysis of activities 2005-2010 
 
- Associated person is one of Arto Urtti ,  Maxim Antopolsky ,  Marika Häkli ,  Päivi Tammela 
,  Lasse Murtomäki , Kim Bergström ,  Antti Petteri Laukkanen, Heidi Kidron , 
 Mari Raki ,  Sanjay Sarkhel ,  Margit Hornof, Julia Lehtinen ,  Astrid 
Elena Subrizi , Kati-Sisko Vellonen ,  Leena Kontturi ,  Mechthild Schmitt , 
 Johanna Linnankoski ,  Melina Malinen ,  Lauri Joonas Paasonen , 
Sreevani Kotha ,  Tatu Lajunen ,  Heikki Tenhu ,  Vladimir 
Aseyev ,  Sami Hietala ,  Anna Viktorovna Zarembo, Susanna Helmi Elisabet Holappa, Markus Nuopponen, Sami-
Pekka Hirvonen ,  Mikko Karesoja ,  Erno Johannes Karjalainen ,  Anu Alhoranta , 
 Jukka Niskanen ,  Petri Pulkkinen ,  Lauri Antero Valtola ,  
Szymon Jan Wiktorowicz ,  Marjo Yliperttula ,  Tapani Viitala ,  Hanna-Sisko 
Kortejärvi ,  Yan-Ru Lou ,  Paraskevi Kallinteri ,  Jonna Wikström , 
 Martina Hanzlikova ,  Niko Granqvist ,  Emilia Marie Claudia Galli , 
 Huamin Liang ,  Unni Kaarina Tengvall ,  Janne Marvola ,  
 
Activity type Count 
Supervisor or co-supervisor of doctoral thesis 23 
Prizes and awards 7 
Editor of research journal 11 
Peer review of manuscripts 48 
Assessment of candidates for academic posts 13 
Membership or other role in review committee 21 
Membership or other role in research network 3 
Membership or other role in national/international committee, council, board 20 
Membership or other role in public Finnish or international organization 5 
Membership or other role of body in private company/organisation 1 
Other tasks of an expert in private sector 5 
Participation in interview for written media 14 
Participation in radio programme 1 
Participation in TV programme 3 
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2 Listing of activities 2005-2010 
Supervisor or co-supervisor of doctoral thesis 
Arto Urtti ,  
Supervision of doctoral thesis, Arto Urtti, 01.01.2005  31.12.2005, Switzerland 
Supervision of doctoral thesis, Arto Urtti, 01.01.2005  31.12.2005, Switzerland 
Supervision of doctoral thesis, Arto Urtti, 01.01.2006  30.12.2006, Finland 
Supervision of doctoral thesis, Arto Urtti, 01.01.2006  30.12.2006, Finland 
Supervision of doctoral thesis, Arto Urtti, 01.01.2006  30.12.2006, Finland 
Supervision of doctoral thesis, Arto Urtti, 01.01.2006  30.12.2006, Finland 
Supervision of doctoral thesis, Arto Urtti, 01.01.2006  30.12.2006, Finland 
Supervision of doctoral thesis, Arto Urtti, 01.01.2006  30.09.2006, Finland 
Marika Häkli ,  
PhD study supervision, Marika Häkli, 2006  27.08.2010 
Päivi Tammela ,  
Supervision of doctoral thesis of Kari Kreander, Päivi Tammela, 2004  2006, Finland 
Supervision of PhD thesis of Leena Pohjala, Päivi Tammela, 2006  2010, Finland 
Supervision of doctoral thesis of Susanna Nybond (on-going), Päivi Tammela, 2010  …, Finland 
Lasse Murtomäki ,  
Supervision, Lasse Murtomäki, 2005  2007, Finland 
Supervision, Lasse Murtomäki, 2007  2010, Finland 
Kim Bergström ,  
Supervisor of PhD thesis in progress, Mirkka Sarparanta, Kim Bergström, 2007  … 
Supervisor of PhD thesis in progress, Teija Koivula, Kim Bergström, 2007  … 
Sanjay Sarkhel ,  
Structural studies of KCC2 C-terminal domain, Sanjay Sarkhel, 2008, Finland 
Structural studies of the KCC2 C-terminal domain, Sanjay Sarkhel, 2009  2010, Finland 
Heikki Tenhu ,  
Complexation of poly(ethyleneoxide)-block-poly(methacrylic acid) in aqueous medium, Heikki Tenhu, 2005 
Thermally responsive polymers based on poly(N-vinylcaprolactam) and an amphiphilic macromonomer, Heikki Tenhu, 2005 
Polymer protected gold nanoparticles, Heikki Tenhu, 2006 
Organized nanostructures of thermoresponsive poly(N-isopropylacrylamide) block copolymers obtained through controlled RAFT 
polymerization, Heikki Tenhu, 2008 
Syntheses and self-assembling characteristics of amphiphilic star diblock copolymers, Heikki Tenhu, 2008 
Prizes and awards 
Arto Urtti ,  
Millennium Distinction Award, Arto Urtti, 15.12.2009 
EUREKA success story nomination, Arto Urtti, 01.01.2010  31.12.2010 
Päivi Tammela ,  
Albert Wuokko Award to Young Scientist, Päivi Tammela, 17.11.2006, Finland 
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Jack L. Beal Award, Päivi Tammela, 14.07.2010, United States 
Lasse Murtomäki ,  
Textbook award, Lasse Murtomäki, 28.06.2008, Finland 
Textbook award, Lasse Murtomäki, 15.09.2009, Finland 
Astrid Elena Subrizi ,  
6th Tissue Engineering Symposium, Astrid Elena Subrizi, 04.06.2009, Finland 
Editor of research journal 
Arto Urtti ,  
AAPS Journal, Arto Urtti, 01.01.2005  31.12.2005, United States 
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, Arto Urtti, 01.01.2005  31.12.2010, Netherlands 
International Journal of Pharmaceutics, Arto Urtti, 01.01.2005  31.12.2010, Netherlands 
Journal of Controlled Release, Arto Urtti, 01.01.2005  31.12.2010 
Journal of Gene Medicine, Arto Urtti, 01.01.2005  31.12.2010, United Kingdom 
Pharmaceutical Research, Arto Urtti, 01.01.2005  31.12.2005, United States 
Advanced Drug Delivery Reviews, Arto Urtti, 01.01.2006  31.12.2006, Netherlands 
J Gene Medicine, Arto Urtti, 01.01.2006  31.12.2010, Netherlands 
Journal of Ocular Cell Biology, Diseases and Bioinformatics, Arto Urtti, 01.11.2007  31.12.2010, United States 
PlosONE, Arto Urtti, 01.01.2007  31.12.2010, United States 
Maxim Antopolsky ,  
Academic editor, Maxim Antopolsky, 03.2008  01.2011 
Peer review of manuscripts 
Arto Urtti ,  
AAPS Journal, Arto Urtti, 01.01.2005  31.12.2005, United States 
European Journal of Pharmaceutical Sciences, Arto Urtti, 01.01.2005  31.12.2010, Netherlands 
INternational Journ al of Pharmaceutics, Arto Urtti, 01.01.2005  31.12.2007, Netherlands 
Journal of Controlled Release, Arto Urtti, 01.01.2005  31.12.2010, Netherlands 
Molecular Therapy, Arto Urtti, 01.01.2005  31.12.2010, United States 
AAPS Journal, Arto Urtti, 01.01.2006  31.12.2006, United States 
Biomacromolecules, Arto Urtti, 01.01.2006  31.12.2010, United States 
Biotechnology and Bioengineering, Arto Urtti, 01.01.2006  31.12.2006, Netherlands 
Investigative Ophthalmology and Visual Sciences, Arto Urtti, 01.01.2006  31.12.2010, United States 
J Colloid and Surhace Chemistry, Arto Urtti, 01.01.2006  31.12.2006, United States 
Journal of Fish Biology, Arto Urtti, 01.01.2006  31.12.2006, United States 
Journal of Gene Medicine, Arto Urtti, 01.01.2006  31.12.2006, United Kingdom 
Pharmaceutical Research, Arto Urtti, 01.01.2006  31.12.2010, United States 
AAPS Journal, Arto Urtti, 01.01.2007  31.12.2007, United States 
Central European Journal of Chemistry, Arto Urtti, 01.01.2007  31.12.2007, Germany 
Gastroenterology, Arto Urtti, 01.01.2007  31.12.2007, United States 
Journal of Gene Medicine, Arto Urtti, 01.01.2007  31.12.2007, United Kingdom 
Nature Biotechnology, Arto Urtti, 01.01.2008  31.12.2009 
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Proc Natl Acad Sci USA, Arto Urtti, 01.01.2008  31.12.2008 
Acta Biomaterialia, Arto Urtti, 01.01.2009  31.12.2009 
Bioanalysis, Arto Urtti, 01.01.2009  31.12.2009 
Cornea, Arto Urtti, 01.01.2009  31.12.2009 
Journal of Pharmaceutical SCiences, Arto Urtti, 01.01.2009  31.12.2009 
Mini-reviews in Medicinal Chemistry, Arto Urtti, 01.01.2009  31.12.2009 
Molecular Pharmaceutics, Arto Urtti, 01.01.2009  31.12.2009 
Oligonucleotides, Arto Urtti, 01.01.2009  31.12.2009 
Recent Patents in Drug Delivery, Arto Urtti, 01.01.2009  31.12.2009 
Theoretical Chemical Accounts, Arto Urtti, 01.01.2009  31.12.2009 
Toxicology, Arto Urtti, 01.01.2009  31.12.2010 
Trends in Biotechnology, Arto Urtti, 01.01.2009  31.12.2009 
Expert Opion in Drug Metabolism and Toxixology, Arto Urtti, 01.01.2010  31.12.2010 
Molecular Vision, Arto Urtti, 01.01.2010  31.12.2010 
Progress in Retinal Research, Arto Urtti, 01.01.2010  31.12.2010 
Päivi Tammela ,  
Peer review for Biochemical Systematics and Ecology, Päivi Tammela, 2005 
Peer review for European Journal of Pharmaceutical Sciences, Päivi Tammela, 2005 
Peer review for European Journal of Pharmacology, Päivi Tammela, 2009 
Peer review for Bioorganic &amp; Medicinal Chemistry, Päivi Tammela, 11.02.2010 
Peer review for Current Topics in Medicinal Chemistry, Päivi Tammela, 27.05.2010, Netherlands 
Lasse Murtomäki ,  
Electrochimica Acta, Lasse Murtomäki, 1992  … 
Journal of Electroanalytical Chemistry, Lasse Murtomäki, 1992  … 
Langmuir, Lasse Murtomäki, 1992  … 
Journal of Controlled Release, Lasse Murtomäki, 1995  … 
Journal of Pharmaceutical Sciences, Lasse Murtomäki, 1995  … 
European Journal of Pharmaceutical Sciences, Lasse Murtomäki, 1998  … 
Kim Bergström ,  
Referee in 8 peer reviewed Journals, Kim Bergström, 1998  … 
Heikki Tenhu ,  
Referee of hundreds of manuscripts for various scientific journals, Heikki Tenhu, 01.01.2005  31.12.2010 
Yan-Ru Lou ,  
American Journal of Physiology - Endocrinology and Metabolism, Yan-Ru Lou, 2010 
Journal of Steroid Biochemistry and Molecular Biology, Yan-Ru Lou, 2010 
Assessment of candidates for academic posts 
Arto Urtti ,  
Professor of Pharmaceutical Technology, University of Basel, Switzerland, 2005, Arto Urtti, 01.01.2005  31.12.2005 
Professor of Drug Delivery, University of Basel, 2006, Arto Urtti, 01.01.2006  31.12.2006 
Professor of Polymer Chemistry, University of Gent, Dept of Organic Chemistry, 2006, Arto Urtti, 01.01.2006  31.12.2006 
Professor of Biopharmaceutics, University of Copenhagen, 2007, Arto Urtti, 01.01.2007  31.12.2007 
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Professor of Molecular Medicine, AIV Institute, University of Kuopio, 2007, Arto Urtti, 01.01.2007  31.12.2007 
Professor of Drug Delivery, University of Basel, 2008, Arto Urtti, 01.01.2008  31.12.2008 
Professor of Gene Transfer Technologies, AIV Institute, University of Kuopio, 2008, Arto Urtti, 01.01.2008  31.12.2008 
Professor of Pharmaceutical Technology, University of Southern Denmark, 2008, Arto Urtti, 01.01.2008  31.12.2008 
Pirjo Laitala-Leinonen, Department of Cell Biology, University of Turku, 2009, Arto Urtti, 01.01.2009  31.12.2009 
Professor in Pharmaceutical Technology, University of KwaZulu Natal, South Africa, 2009, Arto Urtti, 01.01.2009  31.12.2009 
Adjunct Associate Professor, Dept. of Medical Pharmacology, Ohio State University, USA, 2010, Arto Urtti, 01.01.2010  31.12.2010 
Tenure track position Biopharmacy, University of Basel, Switzerland, 2010, Arto Urtti, 01.01.2010  31.12.2010 
Marjo Yliperttula ,  
Member of the professor evaluation board, Marjo Yliperttula, 01.01.2008  31.12.2008 
Membership or other role in review committee 
Arto Urtti ,  
Award Committee Member, Arto Urtti, 01.01.2006  31.12.2007 
Reviewer for Government of Ireland, Embark Initiative (post doctoral fellowships), Arto Urtti, 01.01.2006  31.12.2006 
Reviewer for Luxembourg Ministry of Education, Arto Urtti, 01.01.2006  31.12.2006 
Reviewer for Reseach Council of Catholic University of Leuven, Belgium, Arto Urtti, 01.01.2006  31.12.2006 
Reviewer for Research Council of Norway, Nanotechnology and Materials Program, Arto Urtti, 01.01.2006  31.12.2006 
Reviewer for Austrian Science Academy (2007), Arto Urtti, 01.01.2007  31.12.2007 
Reviewer for Finnish Cultural Foundation Grant Applications 2007, Arto Urtti, 01.01.2007  31.12.2007 
Reviewer for Millennium Award, Arto Urtti, 01.01.2007  31.12.2007 
Reviewer for the Hong Kong Research Council (2007), Arto Urtti, 01.01.2007  31.12.2007 
Reviewer of Infrastructure Grants (FWF Vienna, Austria), 2008, Arto Urtti, 01.01.2008  12.12.2008 
European Union (FP-7, HEALTH program, Arto Urtti, 01.01.2009  31.12.2009 
Grant reviewer for BBSRS Council, UK, 2009, Arto Urtti, 01.01.2009  12.12.2009 
Reviewer for Danish Agency for Science, Technology and Innovation, Arto Urtti, 01.01.2009  12.12.2009 
Reviewer for FWO, Belgium, 2009, Arto Urtti, 01.01.2009  31.12.2009 
Reviewer for Irish Research Council for Science, Engineering and Technology (IRCSET), Arto Urtti, 01.01.2009  12.12.2009 
Reviewer for The Danish Council for Independent Research, Arto Urtti, 01.01.2009  31.12.2009 
NWO Nano STW, The Netherlands, 2010, Arto Urtti, 01.01.2010  01.12.2010 
Reviewer for Innovation and Technology Commission, Hong Kong, 2010, Arto Urtti, 01.01.2010  01.12.2010 
Reviewer for Sigma Delta Epsilon, Graduate Women in Science, National Fellowships, USA,, Arto Urtti, 01.01.2010  01.12.2010 
Kim Bergström ,  
Reviewer of NorFA:s (Nordic Academy of Advanged Study) guest professor, Kim Bergström, 2003  … 
Marjo Yliperttula ,  
Nanotechnology program applications, 2008-9, CEA, CNRS, Marjo Yliperttula, 01.01.2008  31.12.2009 
Membership or other role in research network 
Päivi Tammela ,  
Member of Viikki Research Group Organisation, Päivi Tammela, 2007  …, Finland 
Administrative co-ordinator of the FP7 project MAREX, Päivi Tammela, 01.08.2010  31.07.2014 
Member of American Society of Microbiology, Päivi Tammela, 2010  …, United States 
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Membership or other role in national/international committee, council, board 
Arto Urtti ,  
Health Science Research Council, Academy of Finland, Arto Urtti, 01.01.2005  31.12.2006 
Member-at-Large: Executive Council (EC) of the Globalization of Pharmaceutics Education Network (GPEN), 1.1.2003-31.12.2008, Arto 
Urtti, 01.01.2005  31.12.2008 
Suomen Akatemia, Arto Urtti, 01.01.2005  31.12.2005, Finland 
Nordic Chapter of Controlled Release Society, Arto Urtti, 01.01.2006  31.12.2006, Finland 
Suomen Akatemia, Arto Urtti, 01.01.2006  31.12.2006, Finland 
Suomen Geeniterapiaseura, Arto Urtti, 01.01.2006  31.12.2006, Finland 
University of Gent, Belgium (Dept of Research Affairs), Arto Urtti, 01.01.2006  31.12.2006, Belgium 
Controlled Release Society / Journal of Controlled Release (best paper award evaluator), Arto Urtti, 01.01.2007  31.12.2007, United 
States 
Hong Kong Research Council (arvioija), Arto Urtti, 01.01.2007  31.12.2007, Hong Kong 
Päivi Tammela ,  
Deputy Member of the Committee of Research Affairs, Päivi Tammela, 2004  2006, Finland 
Member of Admissions Board, Päivi Tammela, 2005  2009, Finland 
Deputy Member of the Committee of Educational Affairs, Päivi Tammela, 01.01.2006  31.12.2006, Finland 
Member of the Advisory Committee of the UNDP/DDC Arab States Programme, Päivi Tammela, 2008  … 
Deputy Member of the Committee of Educational Affairs, Päivi Tammela, 2010  … 
Kim Bergström ,  
National Advisor in Radiopharmacy, European Association of Nuclear Medicine, Kim Bergström, 2006  … 
Member of Editorial Board of the Current Radiopharmaceuticals –journal, Kim Bergström, 2007  … 
Supervisor member of Drug Discovery Graduate School (DDGS), Turku, Finland, Kim Bergström, 2007  … 
Astrid Elena Subrizi ,  
Helsinki Drug Research Congress, Astrid Elena Subrizi, 09.06.2008  11.06.2008, Finland 
Heikki Tenhu ,  
The Finnish Society of Sciences and Letters, Heikki Tenhu, 2005 
Board of Natural Sciences and Engineering, Heikki Tenhu, 01.01.2010  31.12.2012 
Membership or other role in public Finnish or international organization 
Arto Urtti ,  
Polymer Corex, Arto Urtti, 01.01.2005  31.12.2005, Finland 
Kim Bergström ,  
Management Committee Member to COST Action B12, Kim Bergström, 1999  2005 
National Coordinator for radiopharmacy teaching program, INSTN, France, Kim Bergström, 1999  2005 
Marjo Yliperttula ,  
Akatemian laskennallisen ohjelmatoimikunnan asiantuntijana, Marjo Yliperttula, 01.01.2008  31.12.2008, Finland 
Yan-Ru Lou ,  
Membership, Yan-Ru Lou, 2004  …, Finland 
Membership or other role of body in private company/organisation 
Kim Bergström ,  
Board Member, Imanext Ltd, Kim Bergström, 2006  2010 
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Other tasks of an expert in private sector 
Arto Urtti ,  
Hallituksen pj, Arto Urtti, 01.01.2005  31.12.2010 
Scientific Advisory Board Member, Arto Urtti, 01.06.2010  31.12.2010 
Scientific Advisory Board Member, Arto Urtti, 01.01.2010  31.12.2010 
Päivi Tammela ,  
Deputy Responsible Pharmacist, Päivi Tammela, 29.04.1999  …, Finland 
Kim Bergström ,  
Senior Advisor in life-science sector, Replicon Group, Kim Bergström, 2006  … 
Participation in interview for written media 
Arto Urtti ,  
Apteekin hyllyltä, Arto Urtti, 01.01.2006  31.12.2006, Finland 
KEMIA-KEMI, Arto Urtti, 01.01.2006  31.12.2006, Finland 
Viikin Kampusesite, Arto Urtti, 01.01.2006  31.12.2006, Finland 
Yliopisto, Arto Urtti, 01.01.2006  31.12.2006, Finland 
Kemia-Kemi, Arto Urtti, 01.01.2008  31.12.2008 
MediUutiset, Arto Urtti, 01.01.2008  31.12.2009, Finland 
MediUutiset, Arto Urtti, 01.01.2008  31.12.2008 
Farmasia -lehden haastattelu, Arto Urtti, 01.01.2009  31.12.2009 
Haastattelu Proviisori -lehteen, Arto Urtti, 01.01.2009  31.12.2009 
APTEEKIN HYLLYLTÄ, Arto Urtti, 01.01.2010  31.12.2010 
Haastattely Tiede -lehteen, Arto Urtti, 01.01.2010  31.12.2010 
Päivi Tammela ,  
Pohjatyötä uusien lääkkeiden hyväksi, Päivi Tammela, 2007, Finland 
Tonneittain tuohta, Päivi Tammela, 18.06.2009, Finland 
Marjo Yliperttula ,  
Ylen haastattelu Studia Generalia luentoon liittyen, Marjo Yliperttula, 20.02.2008  31.12.2011, Finland 
Participation in radio programme 
Päivi Tammela ,  
Radio interview, Päivi Tammela, 05.04.2006, Finland 
Participation in TV programme 
Arto Urtti ,  
TV1 Uutiset , haastattelu, Arto Urtti, 01.01.2008  31.12.2008 
Tv-1 Prisma, Arto Urtti, 01.01.2008  31.12.2011, Finland 
Prisma TV 1 haastattelu, Arto Urtti, 01.01.2009  31.12.2009 
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Web of Science(WoS)-based bibliometrics of the RC’s publications data 1.1.2005-31.12.2010  
by CWTS, Leiden University, the Netherlands 
Research Group: Urtti A 
Basic statistics 
Number of publications (P) 169 
Number of citations (TCS) 1,369 
Number of citations per publication (MCS)   8.14 
Percentage of uncited publications 15% 
Field-normalized number of citations per publication (MNCS)   1.57 
Field-normalized average journal impact (MNJS)   1.46 
Field-normalized proportion highly cited publications (top 10%)   1.60 
Internal coverage    .89 
 
Trend analyses 
 
MNCS 
 
THCP10 
 
MNJS 
Collaboration 
 
Performance (MNCS) by collaboration type 
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